CURRICULUM V S. .P.H., M.S., B.S - College of Pharmacy ... · 2014 – present Professor of...
Transcript of CURRICULUM V S. .P.H., M.S., B.S - College of Pharmacy ... · 2014 – present Professor of...
CURRICULUM VITAE KAREN S. HUDMON, DR.P.H., M.S., B.S.PHARM.
Current Titles and Department Professor of Pharmacy Practice, with tenure Department of Pharmacy Practice College of Pharmacy Purdue University Adjunct Professor (without salary) School of Medicine Indiana University Professor of Clinical Pharmacy (without salary) Department of Clinical Pharmacy School of Pharmacy University of California San Francisco Education 1982 – 1986 Bachelor of Science, Pharmacy, Ohio Northern University
1988 – 1989 Massage Therapist, Virginia Institute of Massage Therapy
1989 – 1991 Master of Science, Pharmacy Care Systems, Auburn University
1991 – 1995 Doctorate of Public Health, The University of Texas School of Public Health Health Promotion and Health Education
1993 – 1995 National Cancer Institute Predoctoral Fellowship in Cancer Prevention Department of Epidemiology, Division of Cancer Prevention The University of Texas MD Anderson Cancer Center
1995 – 1997 Postdoctoral Fellowship in Cancer Prevention Departments of Behavioral Science and Epidemiology, Division of Cancer Prevention The University of Texas MD Anderson Cancer Center Licenses, registrations, and certifications 1986 Virginia pharmacy license # 0202 007917 (inactive status) 1990 Texas pharmacy license # 31804 (active) 2005 American Lung Association – State of Connecticut Trained group facilitator, Freedom From Smoking program 2007 American Pharmacists Association – Lipids Management Certificate
KS Hudmon June 2017
Page 2
Academic and Professional Positions Held 1986 – 1990 Community Pharmacist, Peoples Drug Stores, Inc., Virginia Beach, VA 1990 – 1991 Graduate Research Assistant, School of Pharmacy, Auburn University 1991 – 1993 Research Pharmacist, Department of Pharmacoeconomics, Division of Pharmacy The University of Texas MD Anderson Cancer Center 1995 – 1997 Community Pharmacist (part‐time), Wal‐Mart Pharmacies, Houston, TX 1997 Research Associate, Health Services Research, Palo Alto Medical Foundation 1998 – 2001 Public Health Researcher, Center for Health Sciences, SRI International (formerly
Stanford Research Institute) 1999 – 2001 Assistant Clinical Professor (without salary), University of California San Francisco School of Pharmacy 2001 – 2003 Assistant Clinical Professor, University of California, San Francisco School of Pharmacy 2003 – 2006 Assistant Professor of Epidemiology, Yale University School of Public Health 2003 – 2014 Assistant Clinical Professor (without salary), University of California, San Francisco School of Pharmacy 2006 – 2012 Associate Professor, Purdue University College of Pharmacy 2006 – 2014 Research Affiliate (without salary), Yale University School of Public Health 2012 – 2014 Associate Head for Operations (interim), Department of Pharmacy Practice, Purdue University College of Pharmacy [oversaw Departmental budget, support staff,
and space; coordinated development and move to new space for offices and labs] 2012 – present Professor, Purdue University College of Pharmacy (with tenure) 2014 – present Professor of Clinical Pharmacy (without salary), University of California, San Francisco School of Pharmacy Current Memberships in Scientific, Professional, and Scholarly Societies Member, American Association of Colleges of Pharmacy Member, American Pharmacists Association Member, International Pharmaceutical Federation (FIP) Member, Society for Research on Nicotine & Tobacco Founding member, Pharmacy Partnership for Tobacco Cessation Founding member, North American Quitline Consortium Honors and Awards 2017 Chaney Faculty Scholar Award, the highest research award given to faculty by the Purdue
College of Pharmacy
2017 Purdue University Bravo Award for extensive work and recognition over the past year developing collaborative approaches to tobacco cessation
2016 Public Health Excellence Award, awarded by the US Public Health Service. Presented by Rear Admiral Pamela Schweitzer, Assistant to the Surgeon General, for exceptional contributions and national impact in tobacco cessation education; simultaneously received by collaborator Dr. Robin Corelli (UCSF), as the first two civilians to receive this award
2016 Training and Education Award, awarded by AMSUS (the Society of Federal Health Professionals) to the US Public Health Service Tobacco Cessation Intervention Training Team
KS Hudmon June 2017
Page 3
2014 Purdue University Faculty Scholar Award, recognizes outstanding faculty members who are on an accelerated path for academic distinction
2014 Purdue University Bravo Award for exemplary service in designing and transitioning the Department of Pharmacy Practice to new office space in Eskenazi Hospital
2013 Gold Medal for Best Original Research from the American Society of Healthcare Publication Editors, for a paper published in the June edition of the Journal of the American Academy of Physician Assistants. Citation: Warner ML, Maio C, Hudmon KS. Career patterns of physician assistants: A retrospective longitudinal study. JAAPA 2013;26(6):44‐8.
2012 Outstanding Live CME Activity Award, awarded by the Alliance for CME (the International Association of CME Professionals), for the CS2day ‐ Richmond, Virginia NASCAR tobacco cessation initiative. CS2day is a collaboration of the California Academy of Physicians, CME Enterprise, Healthcare Performance Consulting, Inc., Iowa Foundation for Medical Care, IPMA, Physicians’ Institute for Excellence in Medicine, Purdue University College of Pharmacy, University of Virginia School of Medicine, and University of Wisconsin School of Medicine
2010 Best Practice in Collaboration, awarded by the North American Association for Medical Education and Communication Companies, for the CS2day tobacco cessation initiative
2010 Top 20 Reviewer, the journal of Research in Social and Administrative Pharmacy
2009 Award for Outstanding CME Collaboration, Alliance for CME (the International Association of CME Professionals), for the Cease Smoking Today (CS2day) initiative
2008 Hulman Health Achievement Award for Excellence in Health Science Research, Indiana Public Health Foundation
2008 Clinical Research Paper Award, American Pharmacists Association, for the most outstanding clinical or practice‐based research paper published in the Journal of the American Pharmacists Association within the last two calendar years (co‐awardee with co‐authors Sarino LV, Dang KH, Dianat N, Djihanian H, Natanian N, and Ambrose PJ)
2007 Wiederholt Award, American Pharmacists Association, for the most outstanding research paper published in the Journal of the American Pharmacists Association within the last calendar year (co‐awardee with co‐authors Berger BA and Liang H)
2003 California Medical Association Foundation, Recognition for Outstanding Contribution to the Prescription for Change Advisory Board in advancing tobacco control in California
1995 Interdepartmental Postdoctoral Fellowship in Cancer Prevention, Departments of Behavioral Science and Epidemiology, The University of Texas MD Anderson Cancer Center
1993, 1994 National Cancer Institute Predoctoral Fellowship in Cancer Prevention, The University of Texas MD Anderson Cancer Center
1992 Lamb Scholarship, The University of Texas School of Public Health
1990, 1991 Albert F. Nickel Scholarship, Auburn University School of Pharmacy
1985 Phi Lambda Sigma Pharmacy Leadership Award, Ohio Northern University
KS Hudmon June 2017
Page 4
TEACHING Purdue University / IUPUI 2007 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 150 students Tobacco Cessation Lab Coordinator and facilitator (PHRM 404) 15 hrs, 150 students Practical Aspects of Study Design Lecturer (CLPH 490N) 2 hrs, 20 students 2008 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 150 students Tobacco Cessation Lab Coordinator and facilitator (PHRM 404) 15 hrs, 150 students Research Rotation Preceptor (CLPH 589) 160 hrs, 1 student Practical Aspects of Study Design Lecturer (CLPH 490N) 2 hrs, 20 students Cancer Across the Spectrum Co‐coordinator, problem‐based learning 30 hrs, 6 students Tobacco Dependence and Treatment for Healthcare Professionals 15 hrs, 30 students Co‐coordinator (PHRM 490P) 2009 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 150 students Tobacco Cessation Lab Coordinator and facilitator (PHRM 404) 15 hrs, 150 students Research Rotation Preceptor (CLPH 589) 160 hrs, 1 student Tobacco Dependence and Treatment for Healthcare Professionals 15 hrs Co‐coordinator (PHRM 490P) Practical Aspects of Study Design Lecturer (CLPH 490N) 2 hrs, 15 students Study Design Lecturer (PHAD 464) 75 min, 150 students Pharmacoepidemiology Lecturer (PHAD 464) 75 min, 150 students 2010 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 150 students Tobacco Cessation Lab Coordinator and facilitator (PHRM 404) 15 hrs, 150 students Research Rotation Preceptor (CLPH 589) 320 hrs, 2 students Tobacco Dependence and Treatment for Healthcare Professionals 15 hrs, 30 students Co‐coordinator (PHRM 490P) Practical Aspects of Study Design Lecturer (CLPH 490N) 2 hrs, 15 students Study Design Lecturer (PHAD 464) 75 min, 150 students Graduate Seminar Coordinator and lecturer (PHAD 696) 16 hrs, 13 students 2011 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 150 students Tobacco Cessation Lab Coordinator and facilitator (PHRM 404) 12 hrs, 150 students Research Rotation Preceptor (CLPH 589) 800 hrs, 5 students Practical Aspects of Study Design Lecturer (CLPH 490N) 2 hrs, 25 students Study Design Lecturer (PHAD 464) 75 min, 150 students 2012 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 150 students Tobacco Cessation Lab Coordinator and facilitator (PHRM 404) 12 hrs, 150 students 2013 Tobacco Cessation Lecturer (CHLP 471) 4 hrs, 156 students Tobacco Cessation Lab facilitator (PHRM 404) 12 hrs, 156 students
KS Hudmon June 2017
Page 5
Tobacco Cessation Lecturer (PHRM 827) 4 hrs, 156 students Tobacco Cessation Lab Coordinator and facilitator 12 hrs, 156 students Healthy People 2020 Lecturer (PHRM 827) 1 hr, 156 students Study Design Lecturer (PHRM 827) 1 hr, 156 students Tobacco Sales in Pharmacies Lecturer (PHRM 827) 1 hr, 156 students 2014 Tobacco Cessation Lecturer (PHRM 827) 5 hrs, 156 students Tobacco Cessation Lab Coordinator and facilitator 15 hrs, 156 students Tobacco Sales in Pharmacies Lecturer (PHRM 827) 1 hr, 156 students Forms of Tobacco / e‐cigarettes Lecturer (PHRM 827) 1 hr, 156 students Treating Tobacco Use and Dependence Lecturer (PHRM 845) 1.5 hr, 156 students and an update on e‐cigarettes Population Health Management Core Course Coordinator (PHRM 849) 150 students 2015 (sabbatical year) Tobacco Cessation Lab Coordinator and facilitator 3 hrs, 30 students Tobacco Cessation in Patients Lecturer (IPE with IU nursing and social work) 3 hrs, 47 students with Mental Illness 2016 Tobacco Cessation Lecturer (PHRM 827) 6 hrs, 156 students Tobacco Cessation Lab Coordinator and facilitator 15 hrs, 156 students Clearing the Air on E‐cigarettes Lecturer (PHRM 827) 1 hr, 156 students Medication Safety Lab facilitator 15 hrs, 156 students Motivational Interviewing Lab facilitator 9 hours, 156 students 2017 Tobacco Cessation Lecturer (PHRM 827) 6 hrs, 156 students Tobacco Cessation Lab Coordinator and facilitator 15 hrs, 156 students Clearing the Air on E‐cigarettes Lecturer (PHRM 827) 1 hr, 156 students Intervention Studies & Evaluation Research Lecturer (PHPR 664) 1 hr, 12 students Subject Recruitment & Retention Lecturer (PHPR 664) 1 hr, 12 students Communication – Resistant Provider Lab facilitator 9 hrs, 156 students The Tobacco Epidemic Lecturer, Intro to Public Health Science (HSCI 201) 75 min, 166 students Yale University 2004 Measurement Lecturer, Assessing Tobacco Use and Dependence 1 hr, 40 students Soc & Behav Influences on Health Lecturer, The Tobacco Epidemic 2 hrs, 120 students Prevention Interventions Lecturer, Tobacco Cessation: From Theory to Practice 2 hrs, 20 students 2005 Measurement Lecturer, Assessing Tobacco Use and Dependence 1 hr, 40 students Cancer Epidemiology Lecturer, Tobacco‐Related Cancers 1 hr, 13 students Applied Research Methods for the Social & Behavioral Sciences 30 hrs, 13 students Course Coordinator, Lecturer Soc & Behav Influences on Health Lecturer, The Tobacco Epidemic 2 hrs, 120 students Prevention Interventions Lecturer, Tobacco Cessation: From Theory to Practice 2 hrs, 20 students Epidemiology & Public Health Lecturer, Comprehensive Tobacco Control Programs 1 hr, 40 students 2006
KS Hudmon June 2017
Page 6
Measurement Lecturer, Assessing Tobacco Use and Dependence 1 hr, 40 students Cancer Epidemiology Lecturer, Tobacco‐Related Cancers 1 hr, 18 students Applied Research Methods for the Social & Behavioral Sciences 30 hrs, 7 students Course Coordinator, Lecturer 2007 Soc & Behav Influences on Health Lecturer, The Tobacco Epidemic 2 hrs, 120 students University of California San Francisco 2000 Pharmacy Practicea Lecturer and Workshop Facilitator, Tobacco Cessation 8 hrs, 120 students 2001 Pharmacy Practicea Lecturer and Workshop Facilitator, Tobacco Cessation 8 hrs, 120 students Epidemiology & Biostatisticsb Coordinator, Lecturer, Workshop Facilitator, Tobacco Cessation 4 hrs, 140 students Epidemiology for Pharmacistsa Course Coordinator and Lecturer (16 hrs) 20 hrs, 19 students Pharm Health Policy & Mgmta Co‐Coordinator and Lecturer (2 hrs) 20 hrs, 13 students 2002 Pharm Health Policy & Mgmta Co‐Coordinator and Lecturer, Survey Design (2 hrs) 20 hrs, 13 students Pharmacy Practicea Lecturer and Workshop Facilitator, Tobacco Cessation 8 hrs, 125 students Core Cancer Curriculumb Coordinator, Lecturer, Workshop Facilitator, Tobacco Cessation 4 hrs, 143 students Pharm Health Policy & Mgmta Co‐Coordinator, Lecturer (2 hrs), Computer Lab (2 hrs) 20 hrs, 11 students Study Designa Lecturer, Observational Studies 4 hrs, 11 students Pharm Health Policy & Mgmta Co‐Coordinator and Lecturer, Survey Design (2 hrs) 20 hrs, 7 students 2003 Epidemiology for Pharmacistsa Course Coordinator and Lecturer (18 hrs) 20 hrs, 8 students Pharm Health Policy & Mgmta Co‐Coordinator and Lecturer, Survey Design (2 hrs) 20 hrs, 13 students Study Designa Lecturer, Observational Studies 4 hrs, 11 students Pharm Health Policy & Mgmta Co‐Coordinator 20 hrs, 7 students Core Cancer Curriculumb Coordinator, Lecturer, Workshop Facilitator, Tobacco Cessation 4 hrs, 143 students Pharmacy Practicea Lecturer and Workshop Facilitator, Tobacco Cessation 8 hrs, 125 students Oral Medicinec Coordinator, Lecturer, Workshop Facilitator, Tobacco Cessation 4 hrs, 100 students 2004 Pharmacy Practicea Lecturer and Workshop Facilitator, Tobacco Cessation 4 hrs, 125 students Core Cancer Curriculumb Lecturer and Workshop Facilitator, Tobacco Cessation 3 hrs, 143 students Oral Medicinec Coordinator and Lecturer, Tobacco Cessation 4 hrs, 100 students
a School of Pharmacy; b School of Medicine; c School of Dentistry.
2015 Interprofessional OSCEs Group facilitator 3 hrs, 7 students
Other Teaching Activities 1996 Cancer Prevention course, “Recruitment and adherence in cancer prevention trials” class lecture (1 hour)
at The University of Texas MD Anderson Cancer Center, February 1996.
KS Hudmon June 2017
Page 7
1997 Cancer Prevention course, “Recruitment and adherence in cancer prevention trials” class lecture (1 hour) at The University of Texas MD Anderson Cancer Center, February 1997.
Advanced Program Evaluation course, “Critiquing research proposals” class lecture (2 hours) at The University of Texas School of Public Health, February 1997.
2000 Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) and workshop (3 hours) presented at Western University School of Pharmacy, Pomona, CA, March 2000.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) and workshop (3 hours) presented at University of Southern California School of Pharmacy, Los Angeles, CA, April 2000.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) and workshop (2 hours) presented at University of the Pacific School of Pharmacy, Stockton, CA, November 2000.
2001 Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) and workshop (3 hours) presented at Western University School of Pharmacy, Pomona, CA, April 2001.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) presented at University of Southern California School of Pharmacy, Los Angeles, CA, April 2001.
2002 Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) presented at University of Southern California School of Pharmacy, Los Angeles, CA, April 2002.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (1 hour) presented at University of the Pacific School of Pharmacy, Stockton, CA, November 2002.
2003 Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) presented at University of California San Diego School of Pharmacy, San Diego, CA, January 2003.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (1 hour) presented at University of Southern California School of Pharmacy, Los Angeles, CA, April 2003.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) presented at Western University School of Pharmacy, Pomona, CA, April 2003.
Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (2 hours) presented at Loma Linda University School of Pharmacy, Loma Linda, CA, May 2003.
2004 Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (8 hours) presented at University of Massachusetts College of Pharmacy, Boston, MA, April 2004.
2006 Rx for Change: Pharmacist‐assisted tobacco cessation. Class lecture (8 hours) presented at: University School of Pharmacy, Hampton, VA, May 2006.
2007 The Tobacco Epidemic. Class lecture (2 hours) presented at: Yale University School of Public Health, New Haven, CT, November 2007.
2014 Grant Research: At the interface of pharmacy and public health. Class lecture (1 hour) presented at: The University of Texas ‐ Austin, April 2014.
Research Mentoring Activities Purdue University
2007 – 2008 Gerwyn Makai, Mohammad Hassan (Pharm.D. students) co‐advisor (with A Zillich) for tobacco cessation student project
2008 – 2009
KS Hudmon June 2017
Page 8
Anthony Tardi, Roy LaBarge, Ashley Fulton (Pharm.D. students) co‐advisor (with A Zillich) for tobacco cessation student project
2009 – 2010 Kimberly Beckman, Brittany Cantrell (Pharm.D. students) primary advisor for tobacco cessation student project 2010 – 2012 Matthew Hoch, Pharm.D. (M.S. student) primary advisor for Masters degree and thesis 2010 – 2011 Tom Seto (Pharm.D. student) primary advisor for Pharm.D. project
2011 – 2013 Andrew Roth (Pharm.D. student) advisor for tobacco cessation student project (Recipient of Dean’s Summer Fellowship)
2011 – 2013 Caitlin Frail, Pharm.D. (Fellow and M.S. student) Committee member
2013 – 2015 Stephanie Kleyman, Pharm.D. (Fellow and M.S. student) Committee member
2014 – 2016 Michael Muchnik (Pharm.D. student) advisor for multiple mini interview (MMI) study [student award winner for Undergraduate Research Award, Purdue University]
2014 – 2016 Nicolette Mehas (Pharm.D. student) Research Mentor (Recipient of Dean’s Summer Fellowship) 2015 – 2016 Myra Fu (Pharm.D. student) Co‐advisor for medication adherence student project 2016 – present Nervana Elkhadragy, Pharm.D. (MS/PhD Graduate student) Primary mentor
Yale University 2004 – 2005 Lisa Houston (M.P.H. student) primary advisor, Transdisciplinary Tobacco Use Research Center Fellowship
KS Hudmon June 2017
Page 9
Hassana Ibrahim (M.D. student) primary advisor, Downs Fellowship project 2005 – 2006 Briseis Kilfoy (M.P.H. student) primary advisor, Transdisciplinary Tobacco Use Research Center Fellowship 2008 – 2009 Melinda Manley (Ph.D. student) dissertation ‐ external reader Primary academic advisor for 13 graduate students over three years
University of California San Francisco 2001 – 2002 Kimberly Bardel (Pharm.D. student) primary mentor, student research project Carrie Hazelton (Pharm.D. student) statistical mentor, student research project Alison Lum (Pharm.D. student) primary mentor, student research project Jennifer McIntosh (Pharm.D. student) statistical mentor, student research project Hanh Nguyen (Pharm.D. student) primary mentor, student research project Julie Speckman (Pharm.D. student) primary mentor, student research project
2002 – 2003 Allison Tauman (Pharm.D. student) project mentor, student research project Julia Nguyen (Pharm.D. student) project mentor, student research project
Mai Trieu, Sandra Matsumura, Roselle Reyles (Pharm.D. students) co‐project mentor, student research project Kimberly Bardel, Pharm.D. (resident) primary mentor, residency research project
KS Hudmon June 2017
Page 10
Nancy Nguyen, Pharm.D. (resident) primary mentor, residency research project
Mentor for junior faculty
Mitra Assemi, Pharm.D. UCSF Faculty research mentor (2003 – present) Robin Corelli, Pharm.D. UCSF Faculty research mentor (1999 – present) Kentya Ford, Ph.D. The University of Texas Faculty research mentor (2015 – present) Jasmine Gonzalvo, Pharm.D. Purdue University Faculty mentor (2010 – present) Faculty mentor for ASHP Research Bootcamp awardee Kelly Lee, Pharm.D., M.Sc. University of California San Diego Faculty research mentor (2004 – present)
Research mentor for mini‐sabbatical sponsored by the American Colleges of Clinical Pharmacy (2005 – 2006)
Monica Miller, Pharm.D., M.S. Purdue University Faculty mentor (2011 – present) Alissa Russ, Ph.D. Purdue University Faculty mentor (2016 – present) Margie Snyder, Pharm.D., M.P.H. Purdue University Faculty research mentor (2010 – present) Primary mentor for K Award Sharon Youmans, Pharm.D., M.P.H. University of California San Francisco Faculty research mentor (2005 – 2010) Ashley Vincent, Pharm.D. Purdue University Faculty research mentor (2017 – present) Alan Zillich, Pharm.D. Purdue University Faculty research mentor for VA Career Award
UNIVERSITY AND PUBLIC SERVICE University of California San Francisco 2001 – 2003 Member, University of California San Francisco Center for Health and Community 2001 – 2003 Co‐coordinator, School of Pharmacy Topics in Research Seminar Series
KS Hudmon June 2017
Page 11
2001 – 2003 Member, University of California San Francisco Comprehensive Cancer Center 2002 – 2003 Member, Tobacco Center 2002 – 2003 Member, School of Pharmacy Admissions Committee 2002 – 2003 Member, Communications Subcommittee of Pharmacy Admissions Committee 2002 – 2003 Member, School of Pharmacy Committee on Evaluation of Student Mentoring 2001 – 2004 Member, School of Pharmacy Health Policy and Management Pathway Committee 2001 – 2006 Member, School of Pharmacy Center for Consumer Self‐Care 2003 – present Without Salary (WOS) Faculty Member, School of Pharmacy Yale University 2003 – present Member, Transdisciplinary Tobacco Use Research Center 2004 – 2005 Member, Disciplinary Committee 2004 – 2006 Faculty participant, Robert Wood Johnson Clinical Scholars Program, Community Health Partnerships 2004 – 2006 Member, Yale Cancer Center 2005 – 2006 Member, Medical Studies Advisory Committee 2005 – 2006 Faculty participant, Community Action to Prevent Chronic Disease (CAPCoD) 2005 – 2006 Statistical consultant, Department of Neurology 2005 – 2006 Member, Community Committee, Yale‐Griffin Prevention Research Center 2006 – 2014 Research Affiliate Faculty Member, School of Public Health Purdue University 2007 Chair, Faculty Expectations Committee 2007 – present Member, Graduate Affairs Committee 2007 – 2010 Member, Pharmacy Admissions Committee 2007 – 2008 Member, Strategic Planning Committee 2007 Member, IUPUI University Medical Center Tobacco Working Group 2008 Chair, Faculty Search Committee 2009 Member, Faculty Search Committee 2009 – 2012 Member, Department of Pharmacy Practice Executive Management Committee 2009 – 2010 Chair, Task Force on the Evaluation of Business Services 2010 – 2011 Chair, Task Force on Academic Standards 2012 – 2013 Member, Task Force to Review Pharmacy Practice Graduate Program 2012 – 2014 Member, Department Head Search Committee 2012 – 2014 Associate Head for Operations (Interim), Department of Pharmacy Practice 2016 Member, Teaching Evaluations Committee 2016 Member, Professional Student Annual Review Task Force 2016 – 2017 Member, Tobacco‐Free Campus Initiative 2016 – 2017 Member, Assessment Committee 2016 – 2017 Member, Grade Appeals Committee Public Service 1998 – 2000 Member, Institutional Review Board for the Protection of Human Subjects, Palo Alto Medical
Foundation, Palo Alto, CA
KS Hudmon June 2017
Page 12
1999 Participant, San Mateo County Pharmacists Association “Talk to Your Pharmacist Day” ‐ provided tobacco cessation counseling services to patients
2000 Participant, San Mateo County Pharmacists Association “Talk to Your Pharmacist Day” ‐
provided tobacco cessation counseling services to patients 2000 – 2003 Member, Speakers’ Bureau, San Mateo County Pharmacists Association:
Tobacco prevention lectures, Aragon High School, San Mateo, CA, 2000 Tobacco prevention lectures, Fernando Rivera Middle School, Daly City, CA, 2001 Tobacco prevention lectures, Parkway Middle School, South San Francisco, CA, 2001 Tobacco prevention lectures, Aragon High School, San Mateo, CA, 2001 Tobacco prevention lectures, Fernando Rivera Middle School, Daly City, CA, 2002
2002 Participant, San Mateo County Pharmacists Association “Talk to Your Pharmacist Day” –
provided tobacco cessation counseling services to patients 2003 Participant, San Mateo County Pharmacists Association “Talk to Your Pharmacist Day” –
provided tobacco cessation counseling services to patients 2005 – 2006 Member, Prevention Subcommittee, State of Connecticut Comprehensive Cancer Control Plan 2007 Tobacco Cessation facilitator, Indiana Black Expo health fair, Carver Community Center,
Kokomo, IN, May 2007 2009 Webinar Speaker, Indiana State Department of Health – “Treating Tobacco Use and
Dependence: The OB/GYN patient” available at: http://webinar.isdh.in.gov/p15472437/ External advisor, California Tobacco Control Program (summit participant) 2010 External advisor, Agency for Healthcare Research and Quality (AHRQ) and Westat Pharmacy
Survey on Patient Safety Culture 2011 – present Advisory Board, TobaccoFreeRx, George Washington University 2014 – present Advisor, Indiana Tobacco Prevention and Cessation 2015 Invited participant, Indiana Tobacco Prevention and Cessation Strategic Planning Meeting 2016 Conference planner and co‐host, Indiana Mental Health Tobacco Cessation Summit, August
2016, Indianapolis, IN. Sponsored by Purdue University, Anthem BlueCross BlueShield, Indiana State Department of Health, and the American Lung Association.
PROFESSIONAL ACTIVITIES Service to Professional, Scholarly, Scientific, Educational and Governmental Agencies and Organizations Organizations
KS Hudmon June 2017
Page 13
1998 – 2000 Palo Alto Medical Foundation, Palo Alto, CA Member, Institutional Review Board for the Protection of Human Subjects 1998 – 2002 Rx for Change, California Medical Association Foundation Advisory Board Member 2000 – 2001 Centers for Disease Control and Prevention/National Cancer Institute Task Force Member, Committee on Youth Cessation Evaluation Measures Chair, Outcome Measures Committee 2000 – 2003 San Mateo County Pharmacists Association Member, Pharmacists Speakers Bureau Participant, Talk to your Pharmacist Day (annual) 2000 – 2003 Member, Advisory Board, Prescription for Change – a community‐based initiative to remove tobacco sales from pharmacies 2004 – 2006 University of California San Francisco National Advisory Board, Translating Clinical Guidelines for Treating Tobacco Use and
Dependence into Dental Settings (study funded by NIDCR/NIDA) 2004 – 2006 American Dental Association Appointee, Consultant to the Council on Access, Prevention, and Interprofessional Relations 2005 American Society for Health‐System Pharmacists Primary author, Therapeutic Position Statement on Tobacco Cessation 2005 – 2006 State of Connecticut Comprehensive Cancer Control Plan Member, Prevention Subcommittee 2005 – 2008 American Lung Association – State of Connecticut Trained group facilitator, Freedom From Smoking program 2005 – 2014 GlaxoSmithKline (pharmaceutical company) Development and national implementation of Rx for Change training program for entire
medical sales force (unpaid volunteer) 2005 – 2006 Joint Commission on Accreditation of Healthcare Organizations (JCAHO) National Advisory Board Member, Committee on Smoking Cessation 2005 – 2006 American Society of Health‐System Pharmacists Appointee, Ad Hoc Advisory Panel on Population‐Based Medication Use 2005 – present Member, Speakers’ Bureau, Pharmacy Partnership for Tobacco Cessation 2007 – present Advisor, Indiana Tobacco Prevention and Control 2009 California Tobacco Control Program – Tobacco Cessation Summit participant 2011 – 2014 Member, AHRQ Community Pharmacy Technical Expert Panel 2011 – present Board of Advisors, Tobacco‐Free Pharmacies 2013 – present Co‐Chair, American Association of Colleges of Pharmacy, Public Health SIG, Tobacco Control
Subcommittee 2014 Advisor, Indiana Tobacco Prevention and Cessation 2015 – present US Public Health Service – development of national tobacco cessation training programs for
commissioned officers 2016 Author, with W Lang and N Elkhadragy, of an AACP report for CDC on the role of academic
pharmacy in tobacco cessation and control 2016 Speaker, with Dr. Robin Corelli (UCSF) of global tobacco cessation training program for army
officers Grant Review Activities
KS Hudmon June 2017
Page 14
NIH Reviews 1999 Reviewer, ZRG1 SSS‐D(01) Center for Scientific Review Special Emphasis Panel 07/08/99
Reviewer, ZRG1 SSS‐D(01) Center for Scientific Review Special Emphasis Panel 11/08/99 Reviewer, ZRG1 SSS‐D(02) Center for Scientific Review Special Emphasis Panel 11/09/99
2000 Reviewer, ZRG1 SSS‐D(01) Center for Scientific Review Special Emphasis Panel 03/02/00 Reviewer, ZRG1 SSS‐D(01) Center for Scientific Review Special Emphasis Panel 07/06/00 2001 Reviewer, ZRG1 SSS‐D(10) Center for Scientific Review Special Emphasis Panel 03/01/01
Reviewer, ZRG1 SSS‐D(11) Center for Scientific Review Special Emphasis Panel 06/29/01 Reviewer, ZRG1 SSS‐D(10) Center for Scientific Review Special Emphasis Panel 11/01/01
2002 Chair and Reviewer, ZRG1 SSS‐D(11) Center for Scientific Review Special Emphasis Panel 03/15/02 Chair and Reviewer, ZRG1 SSS‐D(11) Adol Substance Use Prevention & Smoking Cessation 11/22/02 2003 Chair and Reviewer, ZRG1 SSS‐D(11) Drug Prevention and Smoking Cessation 03/21/03 Chair and Reviewer, ZRG1 SSS‐D(12) Smoking Cessation Programs for Adolescents 05/01/03 Chair and Reviewer, ZRG1 SSS‐D(10) Health Education & Disease Management 07/10/03 Chair and Reviewer, ZRG1 SSS‐D(11) Drug Prevention & Smoking Cessation 07/18/03 Chair and Reviewer, ZRG1 SSS‐D(11) Addiction Services and Youth Intervention Programs 11/07/03 2004 Chair and Reviewer, ZRG1 RPHB‐C(11) SBIR Addiction Services and Youth 03/10/04 Chair and Reviewer, ZRG1 RPHB‐C(12) SBIR At‐Risk Children and Parent Training 07/15/04 Chair and Reviewer, ZRG1 RPHB‐C(11) SBIR Addiction Services and Youth 07/16/04 Chair and Reviewer, ZRG1 RPHB‐H(11) SBIR Addiction Related Prevention and Education 11/12/04 Reviewer (telephone), ZRG1 RPHB‐A(02) Smoking Cessation Intervention and Health 11/29/04 2005 Chair and Reviewer, ZRG1 RPHB‐C(12) SBIR: Early Childhood and Teen Risk Behaviors 02/24/05 Chair and Reviewer, ZRG1 RPHB‐C(11) SBIR: Alcohol, Tobacco and Substance Abuse 02/25/05 Chair and Reviewer, ZRG1 RPHB‐J(11) SBIR: Alcohol, Tobacco and Substance Abuse 07/01/05 Chair and Reviewer, ZRG1 RPHB‐C(12) SBIR/STTR: Early Childhood and Teen Risk Behavior 07/15/05 Reviewer (telephone) ZRG1 RPHB‐H (91)(F) Prevention and Cessation of Substance Use 11/03/05 Chair and Reviewer, ZRG1 RPHB‐C(11) SBIR/STTR: Early Childhood Behav & Addictions 11/18/05 2006 Chair and Reviewer, ZRG1 RPHB‐C(11) SBIR/STTR: Early Childhood Behav & Addictions 03/03/06 Chair and Reviewer, ZRG1 RPHB‐C(11) SBIR/STTR: Early Childhood Behav & Addictions 07/10/06 Chair and Reviewer, ZRG1 RPHB‐C(10) SBIR/STTR: Risk Prevention and Health Behavior 10/26‐27/06 2007 Chair and Reviewer, ZRG1 RPHB‐C(10) SBIR/STTR: Risk Prevention and Health Behavior 03/01/07 Chair and Reviewer, ZRG1 RPHB‐C(10) SBIR/STTR: Risk Prevention and Health Behavior 07/09/07 2008 Reviewer, ZRG1 RPHB‐C(10) SBIR/STTR: Risk Prevention and Health Behavior 02/21‐22/08 2010 Reviewer, ZRG1 RPHB‐C(10) SBIR/STTR: Risk Prevention and Health Behavior 02/18‐19/10 2016 Co‐Chair and Reviewer, ZRG1 RPHB C(10) SBIR/STTR: Risk Prevention and Health Behavior 03/17‐18/16 Other Grant Reviews 2002 West Virginia University, Ad hoc Grant Reviewer 2005 Ontario Medical Association, External Reviewer, ongoing research project 2012 Pfizer Medical Education Group/ UCSF Smoking Cessation Leadership Center, tobacco cessation grant
reviews (unpaid reviewer) 2013 University of Kentucky, External Grant Reviewer 2015 University of Kentucky, External Grant Reviewer 2016 Indiana University Cancer Prevention and Control grant program
KS Hudmon June 2017
Page 15
Service to Scholarly and Professional Journals Editorial Activities 2005 – 2006 American Journal of Health‐System Pharmacy Series Editor, The Pharmacist’s Role in Tobacco Cessation 2005 – 2009 Associate Editor, Nicotine & Tobacco Research 2006 – 2009 Editorial Board, Journal of Pharmacy Teaching 2016 – present Editorial Board, Research in Social and Administrative Pharmacy Journal Article Reviewer, past 3 years American Journal of Health‐System Pharmacy American Journal of Pharmaceutical Education Currents in Pharmacy Teaching and Learning Journal of the American Pharmacists Association Journal of Continuing Education in the Health Professions Nicotine & Tobacco Research Patient Education & Counseling Research in Social and Administrative Pharmacy Tobacco Control Consulting Roles 1996 The University of Texas School of Public Health. Documentation of laboratory protocols and
quality control/assurance methods for biological measures for “Project Heartbeat,” Darwin LaBarthe, Ph.D., Principal Investigator
1996 – 1997 Oncology Nursing Society. Statistician for national survey of nurse practitioners, Anita Kinney, Ph.D., Principal Investigator
2001 University of Wisconsin School of Pharmacy. Provision of training for pharmacists and methodological expertise for “Pharmacy‐Based Smoking Cessation Program for Young Adults,” Betty Chewning, Ph.D., Principal Investigator
2001 Ontario Tobacco Research Unit, University of Toronto. Methodologic expertise in a survey study of pharmacists’ current practices in tobacco cessation counseling, Mary Jane Ashley, Ph.D., Principal Investigator
1998 – 2003 The University of Texas MD Anderson Cancer Center. Methodologist and statistician for “Smoking Initiation Among a Multi‐ethnic Population of Youth,” Ellen R. Gritz, Ph.D., Principal Investigator (funded by the National Cancer Institute)
2001 – 2006 The University of Texas MD Anderson Cancer Center. Survey development for “Teen Smoking Prevention and Cessation via CD‐ROM Program,” Alexander V. Prokhorov, M.D., Ph.D., Principal Investigator (funded by the National Cancer Institute)
2001 – 2006 The University of Texas MD Anderson Cancer Center. Survey development and statistical consultant for “A Motivational Intervention for High‐Risk Young Smokers,” Alexander V. Prokhorov, M.D., Ph.D., Principal Investigator (funded by the National Cancer Institute)
2002 – 2006 Georgetown University School of Nursing and Health Studies. Curriculum development and
KS Hudmon June 2017
Page 16
workshop coordination/teaching for “A Summer Institute for Tobacco Control Practices in Nursing,” Janie Heath, RN, MS, CCRN, ANP, ACNP, Principal Investigator (funded by the American Legacy Foundation)
2002 – 2008 University of California San Francisco School of Dentistry. Methodologic expertise for “Behavior Modification, Dentists, and Oral Cancer Control,” Sol Silverman, DDS, Principal Investigator (funded by the National Cancer Institute)
2007 – 2012 The University of Texas MD Anderson Cancer Center. Survey development and methodologic consultant for “Project CASA – Clean Air Safe Air,” Alexander V. Prokhorov, M.D., Ph.D., Principal Investigator (funded by the Flight Attendant Medical Research Institute)
2007 – 2012 The University of Texas MD Anderson Cancer Center. Survey development and methodologic consultant for “Curbing Tobacco Use in Suburban and Rural Schools,” Alexander V. Prokhorov, M.D., Ph.D., Principal Investigator (funded by the National Cancer Institute)
2008 – 2012 University of California Los Angeles. Content expertise for “Web‐based Cessation Training for Nurses in Rural Hospitals,” Linda Sarna, Ph.D., Principal Investigator (funded by the Centers for Disease Control and Prevention)
2009 – 2013 University of California San Diego. Shared curriculum and measurement expertise for “PharmGenEd: Pharmacogenomics Education Program,” Grace Kuo, Pharm.D., Principal Investigator (funded the Centers for Disease Control and Prevention)
2011 – 2013 University of California Los Angeles. Content and measurement expertise for “The Chinese Nurse: Helping Smokers Quit Project,” Linda Sarna, Ph.D., Principal Investigator (funded by Pfizer, Inc.; unpaid consultant)
2014, 2016 MD Anderson Cancer Center. External reviewer, health communication and tobacco regulatory science project. Alexander V. Prokhorov, M.D., Ph.D., Principal Investigator (funded by the FDA and NIH).
Invited Lectures and Seminars International 2000 Expanding the role of the pharmacist in tobacco cessation. Presented at: 11th Annual World
Conference on Tobacco or Health, Chicago, IL, August 2000. Implementation of a tobacco curriculum in California’s pharmacy schools, Model Tobacco Curriculum
Workshop for Health Professionals. Presented at: 11th Annual World Conference on Tobacco or Health, Chicago, IL, August 2000 (panel member and speaker).
Implementation of a tobacco curriculum in California’s pharmacy schools. Presented at: 11th Annual
World Conference on Tobacco or Health, Chicago, IL, August 2000. 2001 Rx for change: Expanding the role of the pharmacist in tobacco cessation. Presented at: Education of
Canadian Pharmacists for their Roles in Smoking Cessation conference, University of Toronto, Canada, October 2001.
KS Hudmon June 2017
Page 17
2003 Co‐Chair, Workshop on “Tobacco cessation counseling: Health‐care provider training on both sides of the Atlantic.” Presented at: 12th World Conference on Tobacco or Health, Helsinki, Finland, August 2003.
Rx for Change: A tobacco‐cessation training program for students in the health professions.
Presented at: 12th World Conference on Tobacco or Health, Helsinki, Finland, August 2003. 2004 Disseminating a Tobacco Curriculum for Pharmacy Schools. Presented at: 64th Annual Congress of the
Federation of International Pharmacists, New Orleans, LA, September 2004. 2006 Rx for Change: Nationwide Dissemination of a Tobacco Curriculum for Health Professional Students.
Presented at: 13th World Conference on Tobacco or Health, Washington, DC, July 2006. 2007 The Pharmacist’s Role in Tobacco Cessation: Training the Workforce en masse—A Dissemination
Example from the United States. Panelist and presenter at: Curbing the Tobacco Pandemic – The Role of the Pharmacist panel, the 67th International Congress of Federation of International Pharmacists, Beijing, China, September 2007.
2008 Rx for Change: Clinician‐Assisted Tobacco Cessation. Pre‐conference train‐the‐trainer program
presented at Holistic Pharmacy Practice: Balancing Evidence and Sensibility conference, Kuantan, Malaysia, August 2008.
Nicotine Dependence and Tobacco Cessation: A Sine Qua Non in health promotion and disease
prevention. Presented at Holistic Pharmacy Practice: Balancing Evidence and Sensibility conference, Kuantan, Malaysia, August 2008.
2009 Emerging Role of Pharmacists in Tobacco Control and Pharmacy Education. Presented for Thai Pharmacy
Council on Tobacco, Bangkok, Thailand, September 2009. Emerging Role of Pharmacists in Tobacco Control and Pharmacy Education. Presented for Deans of
Schools of Pharmacy, Thailand, at Chulalongkorn University, Bangkok, Thailand, September 2009. Experiences in Tobacco Control: A Pharmacist’s Journey. Presented for Associate Deans in Academic
Affairs and Professors in tobacco education/research, Thai Pharmacy Network on Tobacco Meeting, Bangkok, Thailand, September 2009.
Tobacco Education in the US: Past, Present, and Future. Presented for Associate Deans in Academic
Affairs and Professors in tobacco education/research, Thai Pharmacy Network on Tobacco Meeting, Bangkok, Thailand, September 2009.
What’s Next in Tobacco Education? A comparative analysis of education in Thailand and the US. Panel
discussion at Thai Pharmacy Network on Tobacco Meeting, Bangkok, Thailand, September, 2009. 2016 The Role of Pharmacy in Providing Pharmacotherapy for Tobacco Cessation. Panel presentation with T
Hays, N Rigotti, and J Williams at the Mayo Clinic Global Tobacco Dependence Treatment Summit 2016, Rochester, MN, 2016.
KS Hudmon June 2017
Page 18
Developing and Implementing Train‐the‐Trainer Curricula. Presenter and co‐facilitator, with Dr. Beatriz Champagne (Bolivia), at: Mayo Clinic Global Tobacco Dependence Treatment Summit 2016, Rochester, MN, 2016.
National 1998 Racial and ethnic differences in nicotine pharmacokinetics. Presented at: Tobacco Independence
Campaign Sixth Annual Conference, Clearwater Beach, FL, November 1998. Genetics and nicotine dependence. Presented at: Tobacco Independence Campaign Sixth Annual
Conference, Clearwater Beach, FL, November 1998. 2001 Expanding the role of the pharmacist in tobacco cessation. Presented at: University of Michigan
College of Pharmacy, Ann Arbor, MI, January 2001. Rx for Change: Pharmacist‐Assisted Tobacco Cessation. Texas Southern University School of Pharmacy.
Co‐presented with R Corelli and L Kroon. Houston, TX: April 2001. [8‐hour training program]
Rx for Change: Assisting Patients with Tobacco Cessation. University of Utah, College of Nursing Continuing Education Program. Co‐presented with R Corelli. Salt Lake City, UT: April 2001. [9.0 nursing contact hours]
Rx for Change: Pharmacist Assisted Tobacco Cessation. University of Wisconsin, Madison, School of Pharmacy Continuing Education Program. Co‐presented with R Corelli. Madison, WI: June 2001. [8.0 ACPE contact hours]
An empirical approach to expanding pharmacist’s role in tobacco cessation. Presented at: University of Wisconsin Center for Tobacco Research and Intervention, Madison, WI, June 2001.
From theory to practice: Behavioral approaches for treating tobacco dependence. Presented at:
American Society of Health‐System Pharmacists Annual Meeting, Los Angeles, CA, June 2001. 2002 A healthcare team approach to smoking cessation. Presented at: National Cancer Institute, Tobacco
Control Research Branch, State and Community Grantees Meeting, San Diego, CA, January 2002. Applying the Transtheoretical Model of Change to promote persistency with multiple sclerosis
medications. Presented at: Biogen, Inc., Boston, MA, February 2002. Expanding the pharmacist’s role in tobacco cessation: From theory to practice. Presented at:
University of North Carolina School of Pharmacy, Chapel Hill, NC, November 2002. 2003 Rx for Change: Clinician‐Assisted Tobacco Cessation. Summer Institute for Tobacco Control Practices
in Nursing Education. Georgetown School of Nursing and Health Sciences. Co‐presented train‐the‐trainer with R Corelli and L Kroon, Washington, DC, May 2003. [12.0 nursing contact hours]
Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Conference
Coordinator and Co‐presenter with E Chung, R Corelli, L Kroon. Presented at: Rx for Change Summer Workshop 2003, San Francisco, CA, June 2003. [14.5 continuing education hours].
KS Hudmon June 2017
Page 19
Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Conference Coordinator and Co‐presenter with E Chung, R Corelli, B Gundersen, L Kroon, L Sakamoto. Presented at: Rx for Change Summer Workshop 2003, San Francisco, CA, July 2003. [14.5 continuing education hours].
Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Conference
Coordinator and Co‐presenter with R Corelli, B Gundersen, L Kroon. Presented at: Rx for Change Summer Workshop 2003, San Francisco, CA, August 2003. [14.5 continuing education hours].
2004 Rx for Change: Clinician‐Assisted Tobacco Cessation. 2nd Annual Summer Institute for Tobacco Control
Practices in Nursing Education. Co‐presented train‐the‐trainer with R Corelli and J Health at: Georgetown University School of Nursing and Health Sciences, Washington, DC, June 2004. [12.0 nursing contact hours]
Rx for Change: The Journey. Presented at: 2nd Annual Summer Institute for Tobacco Control Practices
in Nursing Education, Georgetown University School of Nursing and Health Studies, Washington DC, June 2004.
Survey Design and Analysis. Presented at: Clinical Literature Access, Analysis, and Evaluation
Conference, University of California San Francisco School of Pharmacy, San Francisco, CA, July 2004. Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Conference
Coordinator and Co‐presenter with B Berger, E Chung, R Corelli, B Gundersen, L Kroon, F Vitale. Presented at: Rx for Change Summer Workshop 2004, San Francisco, CA, July 2004. [14.5 continuing education hours].
2005 Creating a Roadmap for Pharmacy’s Future Role in Tobacco Cessation. Presented at: American
Association of Colleges of Pharmacy Interim Meeting, Washington, DC, February 2005. Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program.
Conference Coordinator and Co‐presenter with E Chung, R Corelli, B Gundersen, L Kroon, F Vitale. Presented at: Rx for Change Summer Workshop 2005, San Francisco, CA, August 2005. [14.5 continuing education hours].
2006 Overview of Grant Writing and Common Pitfalls. Presented at: American Colleges of Clinical
Pharmacy, Monterey, CA, May 2006. Development and Nationwide Dissemination of a Tobacco Curriculum for Health Professional
Students. Web seminar for Bacchus Organization, June 2006. Development and Nationwide Dissemination of a Tobacco Curriculum for Health Professionals. Web
seminar for Ohio KePRO, the Ohio Department of Health, and the American Heart Association, November 2006.
2007 The Pharmacy Partnership for Tobacco Cessation: A Role for Pharmacists. Presented at: American
Society of Health‐System Pharmacists, Bethesda, MD, January 2007. Teaching Health Behavior Change Strategies in Pharmacy Curricula. Co‐presenter with B Berger.
Presented at American Association of Colleges of Pharmacy Annual Meeting, Orlando, FL, July 2007.
KS Hudmon June 2017
Page 20
2009 Tobacco Free for Recovery: Assisting Mental Health Consumers with Tobacco Cessation. Webinar
presented for the UCSF Smoking Cessation Leadership Center, April 2009. Tobacco Free for Recovery: Assisting Mental Health Consumers with Tobacco Cessation. Webinar
presented for the UCSF Smoking Cessation Leadership Center, October 2009. Do Ask, Do Tell: A Practical Approach to Smoking Cessation. Presented at Florida Pharmacists
Association Annual Meeting, October, 2009.
2011 Caring for Patients with Cardiovascular Disease: Focus on Tobacco Cessation. Co‐presented with Dr. Larry Dent, at: American Pharmacists Association Annual Meeting and Exposition, Seattle, WA, March 2011.
2013 Assessing and Assisting Patients Tobacco Cessation Efforts in Pharmacy Practice. Co‐presented with Dr. Robin Corelli, at: American Pharmacists Association Annual Meeting and Exposition, Los Angeles, CA, March 2013.
Tales of the City: Banning Tobacco Sales in San Francisco Pharmacies. Co‐presented with Dr. Mitchell Katz, webinar hosted by the UCSF Smoking Cessation Leadership Center, March 2013.
2015 The Health Impact of Tobacco Use and Cessation. Live webinar, presented for: Home Health Quality
Improvement organization, CardioLAN monthly meeting, February 19, 2015.
Be Smoke Free: Addressing Tobacco Cessation in Pharmacy Practice. Co‐presented with Dr. Robin Corelli, at: American Pharmacists Association Annual Meeting and Exposition, San Diego, CA, March 2015.
Integrating Medications into Smoking Cessation Treatment: The Basics. Co‐presented with Dr. Robin Corelli, webinar hosted by the UCSF Smoking Cessation Leadership Center, September 2015.
Rx for Change: Tobacco Cessation in Respiratory Care. Co‐presented with Drs. Robin Corelli and Frank Vitale, live webinar, October 9, 2015.
Rx for Change: Tobacco Cessation in Respiratory Care. Co‐presented with Drs. Robin Corelli and Frank Vitale, live webinar, November 2 and 4, 2015.
Rx for Change: Tobacco Cessation in Respiratory Care. Co‐presented with Dr. Robin Corelli and Frank Vitale, live webinar, December 2, 2015.
2016 Rx for Change: Tobacco Cessation in Respiratory Care. Co‐presented with Dr. Robin Corelli and Frank Vitale, live webinar, January 2016.
Beyond the Basics: Pharmacotherapy for Smoking Cessation. Co‐presented with Dr. Robin Corelli, webinar hosted by the UCSF Smoking Cessation Leadership Center, March 2016.
Clearing the Air on E‐cigarettes. Co‐presented with Dr. Robin Corelli, at: American Pharmacists Association Annual Meeting and Exposition, Baltimore, MD, March 2016.
2017 Beyond the Basics: Maximizing Chances for Smoking Cessation. Co‐presented with Dr. Robin Corelli, at: American Pharmacists Association Annual Meeting and Exposition, San Francisco, CA, March 2017.
Expert Debate: Weighing the Harms and Benefits of Electronic Nicotine Delivery Systems. American Pharmacists Association Annual Meeting and Exposition, Baltimore, MD, March 2016.
KS Hudmon June 2017
Page 21
State or Regional 2000 Development of a tobacco curriculum for pharmacy students. Presented at: California Medical
Association Foundation, San Francisco, July 2000. 2001 California pharm‐assists for tobacco cessation. Presented at: California Tobacco Education and
Research Oversight Committee meeting, Burlingame, CA, February 2001. 2003 360 degrees of cessation. Presenter and panelist at: California State Department of Health Services,
Tobacco Control Section, Project Director's Meeting, Newport Beach, CA, April 2003. Tackling tobacco: the pharmacist’s role in helping patients quit. Presentation at the California State
Capitol, Sacramento, CA, April 2003. 2006 Development and Nationwide Dissemination of a Tobacco Curriculum for Health Professional
Students. Conference seminar for Ohio Tobacco Control Statewide Strategic Plan Cessation Work Group, August 2006.
Tobacco Cessation Counseling: A Protocol for Practicing Pharmacists. Presented at: Annual Meeting
of the Alabama Society for Health‐System Pharmacists, Pelham, AL, October 2006.
Tobacco‐Related Research at IUPUI. Co‐presented with A McDaniel and A Zillich at: Walther Cancer Institute–Behavioral Cooperative Oncology Group Annual Meeting, Indianapolis, IN, December 2006.
Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Co‐
presenter with F Vitale. Presented at: Bacchus Organization, Cleveland, OH, November 2006. 2007 Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Co‐
presenter with F Vitale. Presented at: Oregon State Health Department, Portland, OR, October 2007. 2008 Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Train‐the‐Trainer Program. Co‐
presenter with F Vitale. Presented at: Michigan Pharmacists Association, Gaylord, MI, September 2008 [8‐hour training].
Smoking Cessation: What works? Presented at: Indiana Cancer Consortium, Indianapolis, IN, October
2008 [1‐hour training]. 2009 Smoking Cessation: Pharmacologic Management. Presented at: Valparaiso College of Nursing,
Pharmacology Update for Advanced Practice Nurses, Valparaiso, IN, April 2009. Treating Tobacco Use and Dependence: The OB/GYN patient. Webinar Speaker, Indiana State
Department of Health, May 2009. [1.0 continuing education hours]. Indiana’s Place‐Based Cessation Partnership Plan. Presented with K Sneegas at: Indiana Public Health
Association Annual Meeting, Indianapolis, IN, June 2009.
KS Hudmon June 2017
Page 22
What Works in Tobacco Use Cessation. Presented with K Sneegas at: 2009 Indiana Summit on
Smoking Cessation, Indianapolis, IN, December 2009. 2011 Ask‐Advise‐Refer: Brief Interventions for Assisting Patients with Quitting. Presented at: Columbus
Regional Health Medical Center, Columbus, IN, November 2011. 2012 Public Health Pharmacy: Research and Practice. Presented at: Ohio Northern University College of
Pharmacy, March 2012. 2014 Where There’s Vapor, Is There Fire? Update on electronic cigarettes for smoking cessation. Presented
at: Indiana State Department of Health, Partner X‐Change Conference 2014, Indianapolis, IN, June 2014.
The Power of Academic Detailing in Quitline Promotion. Presented at: Indiana State Department of
Health, Partner X‐Change Conference 2014, Indianapolis, IN, June 2014. 2016 Pharmacotherapy for Smoking Cessation. Presented at: Indiana Mental Health Tobacco Cessation
Summit, August 2016, Indianapolis, IN. Local 1993 Evaluating the effects of computer‐assisted instruction in diabetes education: Instrument
development and validation. Presented at: The University of Texas School of Public Health, Houston, TX, February 1993.
1995 Behavioral facets of cancer chemoprevention trials. Presented at: The University of Texas School of
Public Health, Houston, TX, October 1995. Perceptions of participation in a cancer chemoprevention trial. Presented at: Division of Cancer
Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, July 1995. 1996 The pharmacology of nicotine. Presented at: Department of Behavioral Science, The University of
Texas MD Anderson Cancer Center, Houston, TX, November 1996. The pharmacology of nicotine. Presented at: Department of Epidemiology, The University of Texas
MD Anderson Cancer Center, Houston, TX, November 1996. 1998 The pharmacology and genetics of nicotine addiction. Presented at: SRI International, Menlo Park,
CA, June 1998. 1999 Keys to success for transitioning from a post‐doc position to an independent investigator in a non‐
academic institution. Panel discussant, Stanford University, Palo Alto, CA, July 1999. 2000 Promoting the pharmacists’ role in tobacco cessation: A summary of current research. Presented at:
SRI International, Menlo Park, CA, June 2000.
KS Hudmon June 2017
Page 23
2001 Research 101: Getting started. Presented at: University of California San Francisco School of Pharmacy Topics in Research Seminar Series, San Francisco, CA, October 2001.
2002 A Rx for change: Expanding the role of the pharmacist in tobacco cessation. Presented at University
of California San Francisco School of Pharmacy Board of Overseers Meeting, November 2002. Estimating risk. Presented at: University of California San Francisco School of Pharmacy Topics in
Research Seminar Series, San Francisco, CA, January 2002. Survey Design and Analysis, Part 1. Presented at: University of California San Francisco School of
Pharmacy Topics in Research Seminar Series, San Francisco, CA, March 2002. Survey Design and Analysis, Part 2. Presented at: University of California San Francisco School of
Pharmacy Topics in Research Seminar Series, San Francisco, CA, April 2002. Tackling Tobacco: The Pharmacist’s Role in Helping Patients Quit. Presented at: University of
California San Francisco School of Pharmacy Homecoming, San Francisco, CA, October 2002 [2 continuing education hours].
SPSS Statistical Software Workshop. Presented at: University of California San Francisco School of
Pharmacy, San Francisco, CA, November 2002. 2004 Nationwide dissemination of a tobacco curriculum for students in the health professions. Presented
at Yale University Transdisciplinary Tobacco Use Research Center Seminar, April 2004. 2005 Tobacco cessation: The individual and the environment. Presented at Yale University Occupational
Medicine seminar, Epidemiology of Microbial Diseases program, March 2005. 2006 The clinician’s role in tobacco cessation. Presented at: Yale Cancer Center, Cancer Prevention and
Control seminar, January 2006. 2007 Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Presented at: Lorain Community
College, Cleveland, OH, March 2007. Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Presented at: Cuyahoga Community
College, Cleveland, OH, March 2007. Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Presented at: Kent State University –
Geauga campus, Geauga, OH, March 2007. Rx for Change: Clinician‐Assisted Tobacco Cessation Curriculum. Presented at: Kent State University –
Salem campus, Salem, OH, March 2007. Rx for Change: Clinician‐Assisted Tobacco Cessation. Co‐presenter with A Zillich. Presented at:
Borgess Health, Kalamazoo, MI, August 2007. Rx for Change: Clinician‐Assisted Tobacco Cessation. Co‐presenter with A Zillich. Presented at:
Bronson Medical Center, Kalamazoo, MI, August 2007.
KS Hudmon June 2017
Page 24
2009 Treating Tobacco Use and Dependence: The OB/GYN Patient. Presented at: IUPUI School of Medicine
Grand Rounds, March 2009. 2012 Public Health Pharmacy: Research and Practice. Presented at: Ohio Northern University, March 2012. 2014 Grant Research: At the Interface of Pharmacy and Public Health. Presented at: The University of Texas
School of Pharmacy (web‐based), April 2014.
Expanding the Clinician’s Role in Tobacco Cessation: From Theory to Practice. Presented at: Indiana University Simon Cancer Center, April 2014.
The Expanding Role of Pharmacists in Tobacco Cessation. Presented at: University of Illinois Chicago
(UIC), July 2014. 2016 Expanding the Clinician’s Role in Tobacco Cessation: From Theory to Practice. Presented at: University of
Minnesota, May 2016. Navigating Treatment Options for Smoking Cessation. Presented at: Indiana University Health Pharmacology for Advanced Practice Nurses conference, September 2016.
Ask‐Advise‐Refer: Brief tobacco cessation interventions in community pharmacy practice. Presented at:
Purdue University, August 2016. Impact of OSCE video review on student self‐assessment. Presented with A Isaacs, N Elkhadragy at:
Purdue University, November 2016. 2017 Tobacco Cessation Education: Next Steps for Translating Skills into Clinical Practice. Presented at:
Northeastern University, January 2017. Papers and Posters Presented at Meetings (Refereed) 1994 Hudmon KS, Chamberlain RM. A comparison of participants and eligible nonparticipants in a head
and neck cancer chemoprevention trial. Presented at: Fourth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer, September 1994, Arlington, VA. [Poster]
1995 Chamberlain RM, Spitz MS, Fueger JF, Hudmon KS. Health knowledge and beliefs in African‐ and
Mexican‐Americans. Presented at: American Society of Preventive Oncology, March 1995, Houston, TX. [Poster] Hudmon KS, Chamberlain RM. Participants' perceptions of a colon cancer chemoprevention trial. Presented at: American Society of Preventive Oncology, March 1995, Houston, TX. [Poster]
1996 Hudmon KS, Chamberlain RM. Participation of ethnic minorities in cancer chemoprevention trials. Presented at: Conference on The Recruitment and Retention of Minority Participants in Clinical Cancer Research. January 1996, Washington, D.C. [Poster]
KS Hudmon June 2017
Page 25
Prokhorov AV, Schacherer CW, Hudmon KS, Quinones M, Gritz ER. Psychometric properties of the Decisional Balance Scale for smoking initiation in youth. Presented at: American Society of Preventive Oncology 20th Annual Meeting, March 1996, Bethesda, MD. [Poster] Hudmon KS, Prokhorov AV, Schacherer CW, Quinones M, Gritz ER. A psychometric evaluation of the Temptations to Try Smoking Inventory in adolescents. Presented at: American Society of Preventive Oncology 20th Annual Meeting, March 1996, Bethesda, MD. [Poster] Hudmon KS, Chamberlain RM. Results of an interim analysis of adherence data from a head and neck cancer chemoprevention trial. Presented at: American Society of Preventive Oncology 20th Annual Meeting, March 1996, Bethesda, MD. [Poster] Hudmon KS, Chamberlain RM. Outcomes of a placebo run‐in period in a cancer chemoprevention trial. Presented at: Society for Clinical Trials 17th Annual Meeting, May 1996, Pittsburgh, PA. [Poster]
1997 Strom C, Chamberlain RM, Koehly LM, Hudmon KS, Spitz MR. Eyes and Ears: Sources of Health Information Among Minorities. Presented at: the American Society of Preventive Oncology 21st Annual Meeting, March 1997, New Orleans, LA. [Poster] Prokhorov AV, Koehly LM, Hudmon KS, Pallonen UE. Measuring adolescent nicotine dependence with a modified version of the FTQ: A longitudinal study. Presented at: the Society of Behavioral Medicine 18th Annual Scientific Session, April 1997, San Francisco, CA. [Poster] Sockrider MM, Hudmon KS, Mullen PD, Addy R, Hammond SK. Home smoking policy and control of infant passive smoke exposure. Presented at: the American Thoracic Society Annual Meeting, May 1997, San Francisco, CA. [Poster]
1998 Gritz ER, Prokhorov AV, Hudmon KS, Chamberlain RM, Taylor WC. Cigarette smoking in a multiethnic sample of youth: Baseline findings. Presented at: The Society of Behavioral Medicine 19PthP Annual Meeting, March 1998, New Orleans, LA. [Poster]
1999 Prokhorov AV, Hudmon KS, de Moor CA, Hu S, Kelder SH, Gritz ER. Predicting adolescent smoking
initiation: Evidence for a single model that combines the Stages of Change and Susceptibility to Smoking constructs. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, March 1999, San Diego, CA and at the American Society of Preventive Oncology 23rd Annual Meeting, March 1999, Houston, TX. [Poster]
2000 Swan GE, Carmelli D, Hudmon KS, Andrews J, Severson HH. Familial aggregation of smokeless tobacco
use: Evidence for genetic influence? Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2000, Arlington, VA. [Poster] Hudmon KS, Prokhorov AV, Corelli RL, Krasnow R, Trondsen L. Helping tobacco users to quit: Pharmacists’ counseling role. Presented at: American Society for Preventive Oncology 24th Annual Meeting, March 2000, Bethesda, MD. [Poster] Brigham J, Javitz H, Hudmon KS, Pomerleau CS, Marks JL, McElroy M, Swan GE. Lifetime tobacco use questionnaire: Examining lifespan tobacco exposure. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2000, Arlington, VA. [Poster]
KS Hudmon June 2017
Page 26
Hudmon KS, Marks JL, Pomerleau CS, Brigham J, Swan GE. A multi‐dimensional approach to measuring nicotine dependence. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2000, Arlington, VA. [Poster] Hudmon KS, Brigham J, Hemberger K, Shreve MS. California Pharm‐Assists for Tobacco Cessation: Expanding the role of the pharmacist. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2000, Arlington, VA. [Poster] Corelli RL, Hudmon KS, Kroon LA, Sakamoto LM, Chung E, Paynter M. Rx for change: Pharmacist‐assisted tobacco cessation©‐‐ Implementing a tobacco cessation curriculum in California pharmacy schools. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2000, San Diego, CA and at the 11th World Conference on Tobacco or Health, August 2000, Chicago, IL. [Poster] Swan GE, Cheng L, Carmelli D, Hudmon KS, Hemberger KK, Hops H, Andrews J, Tildesley L, McBride D. Complex segregation analysis of smoking in families: Evidence for a genetic mode of transmission in nuclear families with a high prevalence of smoking. Presented at: University of California Tobacco‐Related Disease Research Program Annual Meeting, December 2000, San Diego, CA. [Poster]
2002 Swan GE, Javitz H, Jack LM, Hops H, Andrews J, Tildesley E, McBride D, Hemberger K, Hudmon KS, Carmelli D. Evidence that tobacco use trajectories in adolescents are associated with smoking among first‐degree relatives. Presented at: Society for Research on Nicotine and Tobacco Annual Meeting, February 2002, Savannah, GA. [Poster] Hudmon KS, Hemberger KK, Corelli RL, Kroon LA, Prokhorov AV. NonRx nicotine replacement therapy: Pharmacists’ counseling role. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2002, Kansas City, MO. [Poster] Swan GE, Hudmon KS, Carmelli D, Hemberger KK, Khroyan T, Ring H, Cheng L, Hops H, Andrews J, Tildesley E, McBride D, Wilhelmsen K, Benowitz N, Koenig B, Iles J. Environmental and genetic determinants of tobacco use: A multidisciplinary, longitudinal family‐based design. Presented at: University of California Tobacco‐Related Disease Research Program Annual Meeting, December 2002, San Jose, CA. [Poster] Swan GE, Javitz H, Jack LM, Hops H, Andrews J, Tildesley E, McBride D, Hemberger KK, Hudmon KS, Carmelli D. Evidence that tobacco use trajectories in adolescents are associated with smoking among first‐degree relatives. Presented at: University of California Tobacco‐Related Disease Research Program Annual Meeting, December 2002, San Jose, CA. [Poster] Swan GE, Cheng L, Carmelli D, Hops H, Andrews J, Tildesley E, Hemberger KK, Hudmon KS. Genetic and environmental influences on multiple tobacco‐related phenotypes in families. Presented at: University of California Tobacco‐Related Disease Research Program Annual Meeting, December 2002, San Jose, CA. [Poster] Swan GE, Jack LM, Carmelli D, Hemberger KK, Ring H, Cheng L, Hops H, Andrews J, Tildesley E, McBride D, Hudmon KS. Agreement between proband and family members’ report of smoking behavior. Presented at: University of California Tobacco‐Related Disease Research Program Annual Meeting, December 2002, San Jose, CA. [Poster]
KS Hudmon June 2017
Page 27
2003 Hudmon KS, Fenlon C, Corelli RL, Kroon LA, Lem K, Prokhorov AV. Tobacco sales in community
pharmacies: time for a change? Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2003, Minneapolis, MN. [Poster] Bardel K, Hudmon KS, Corelli RL, Kroon LA, Fenlon C, Lem K. Tobacco cessation training in U.S. schools of pharmacy: content, methods, and perceived barriers to change. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2003, Minneapolis, MN. [Poster] Assemi M, Hudmon KS, Cullander C. Fostering cultural competency in pharmacy students. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2003, Minneapolis, MN. [Poster] Sauer BL, Youmans SL, Winter ME, Corelli RL, Hudmon KS, Inciardi JF, Young LL. Student research projects as a foundation for career success. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2003, Minneapolis, MN. [Poster] Brigham J, Pomerleau CS, Javitz HS, Hudmon KS, Swan GE. Predicting later tobacco use from early exposure: results from the Lifetime Tobacco Use Questionnaire. Presented at: World Conference on Tobacco or Health, August 2003, Helsinki, Finland. [Platform presentation]
2004 Eule B, Sullivan MK, Schroeder SA, Hudmon KS. Merchandising of cigarettes in San Francisco pharmacies: 27 years later. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2004, Scottsdale, AZ. [Poster] Hudmon KS, Corelli RL, Fenlon C, Kroon L, Lem K, Heath J. Nationwide dissemination of a tobacco curriculum for health professional students. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2004, Scottsdale, AZ. [Poster] Fenlon CM, Corelli RL, Hudmon KS. California consumers’attitudes toward tobacco sales in chain drug stores. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2004, Scottsdale, AZ. [Poster] Hudmon KS, Pomerleau CS, Javitz H, Brigham J, Swan G. Validity of Retrospective Assessments of Nicotine Dependence. Presented at: the Society for Research on Nicotine and Tobacco Annual Meeting, February 2004, Scottsdale, AZ. [Poster] Corelli R, Fenlon C, Kroon L, Lem K, Sullivan MK, Hudmon KS. Nationwide dissemination of the Rx for Change tobacco cessation curriculum: impact of a train‐the‐trainer program for pharmacy faculty. Presented at: American Pharmacists Association Annual Meeting, March 2004, Seattle, WA. [Platform presentation] Berger BA, Hudmon KS, Liang H. Predicting discontinuation of treatment among patients with multiple sclerosis: an application of the Transtheoretical Model of Change. Presented at: American Pharmacists Association Annual Meeting, March 2004, Seattle, WA. [Platform presentation]
KS Hudmon June 2017
Page 28
Corelli RL, Hudmon KS, Fenlon C, Kroon LA, Lem K. The Rx for Change: Pharmacist‐Assisted Tobacco Cessation Program An Update on its Dissemination to the U.S. Schools of Pharmacy. Presented at American Association of Colleges of Pharmacy Annual Meeting, July 2004, Salt Lake City, MN. [Poster] Houston LA, Warner M, Fenlon CM, Corelli RL, Hudmon KS. Tobacco cessation training in U.S. physician assistant programs. Presented at: Association of Physician Assistant Programs 2004 Annual Education Forum and Exhibition, November 2004, Nashville, TN. [Platform presentation]
2005 Hudmon KS. A Roadmap for Pharmacy’s Future Role in Tobacco Cessation. Panel presenter: Performance Partnerships: A Model to Maximize Resources, Measure Results. Presented at: 2005 National Conference on Tobacco or Health in Chicago, Illinois, May 2005. [Platform presentation]
Lessov CN, Brigham J, Hudmon KS, Hops H, Andrews JA, Tildesley L, Swan GE. Dimensionality of tobacco
dependence: A principal components analysis. Presented at: Society for Research on Nicotine and Tobacco Annual Meeting, March 2005, Prague, Czech Republic.[Poster]
Hudmon KS, Corelli RL, Fenlon CM, Kroon LA, Lem K, Prokhorov AV. Rx for Change: Clinician‐Assisted Tobacco Cessation – A study of factors influencing program dissemination and implementation. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2005, Cincinnati, OH. [Poster] Hudmon KS, Corelli RL, Fenlon CM, Hussar D. Pharmacy student perceptions of tobacco sales in pharmacies and suggested methods for promoting tobacco‐free experiential sites. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2005, Cincinnati, OH. [Poster]
2006 Hudmon KS, Fenlon CM, Kroon LA, Corelli RL, Prokhorov AV. Factors influencing anticipated adoption of a tobacco curriculum for health professional students. Presented at: Society for Research on Nicotine and Tobacco Annual Meeting, March 2006, Orlando, FL. [Poster]
Assemi M, Hudmon KS. Implementation and evaluation of cultural competence training content in the first year core curriculum. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2006, San Diego, CA. [Poster]
Assemi M, Mutha S, Hudmon KS. Implementation and evaluation of a faculty development course in
cultural competency for pharmacy educators. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2006, San Diego, CA. [Poster]
Corelli RL, Hudmon KS, Fenlon CM, Kroon LA, Lem K, Prokhorov AV. Rx for Change: Clinician‐Assisted Tobacco Cessation—evaluation of a train‐the‐trainer workshop for pharmacy faculty. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2006, San Diego, CA. [Poster] Hudmon KS, Corelli RL, Kroon LA, Fenlon CM, Prokhorov AV. Rx for Change: Clinician‐Assisted Tobacco Cessation: dissemination of a shared, national tobacco curriculum for health professional students. Presented at: American Association of Cancer Education, October 2006, San Diego, CA. [Platform presentation]
KS Hudmon June 2017
Page 29
2007 Bock BC, Bock FR, Hudmon KS, Christian JG. Characteristics and attitudes toward smoking intervention among pharmacy clients. Presented at: Annual Meeting of the Society for Behavioral Medicine, March 2007, Washington DC [Poster].
Zillich AJ,T Hudmon KS, McDaniel AM. Transforming health care students’ access to tobacco cessation
knowledge through distance education. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Orlando, FL, July 2007. [Poster]
2008 Lee KC, El‐Ibiary SY, Hudmon KS. Evaluation of research training and productivity among junior pharmacy
faculty in the U.S. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2008, Chicago, IL. [Poster] Nasrawi S, Kao D, Hudmon KS, Corelli RL. Evaluation of a required senior research project in a doctor of pharmacy curriculum. Presented at: American Association of Colleges of Pharmacy Annual Meeting, July 2008, Chicago, IL. [Poster] Tardi AM, LaBarge RA, Fulton AM, Maylath NS, Farkas AP, Hudmon KS, Zillich AJ. Implementation of a student pharmacist tobacco cessation program. Presented at American College of Clinical Pharmacy Annual Meeting, October 2008. Published Abstract, Pharmacotherapy 2008;28(9):212. [Poster] Beckman E, Hudmon KS, Kalsekar ID, Knoderer H, Morris J. Prevalence of venous thrombosis in a pediatric hospital. Presented at American Society of Health‐Systems Pharmacists, December 2008, Orlando, FL. [Poster and platform presentation]
2009 Hudmon KS, Zillich AJ, Birk C, Hultgren K, Flynn EA. Survey of Medication Safety Culture in Indiana Community Pharmacies. Presented at: American Pharmacists Association (APhA) Annual Meeting & Exposition, April 2009, San Antonio, Texas. [Poster]
Zillich AJ, Gonzalvo JD, Jaynes H, Hudmon KS, Frankel RM, Doebbeling BN. Collaboration among physicians and pharmacists in VA primary care. Presented at: Department of Veterans Affairs Health Services Research & Development National Meeting, February 2009, Baltimore, MD. [Poster] Bock B, Graham A, Christian J, Hudmon KS, Bock B. Pharmacist advice for smoking cessation: Does pharmacist gender matter? Presented at: Society for Research on Nicotine and Tobacco ‐ Europe, March 2009, Dublin, Ireland. [Poster]
2010 Schmelz AN, Zillich AJ, Fenlon C, Hudmon KS. Enhancing tobacco cessation counseling among cancer care providers through web‐based learning. Presented at: American Colleges of Clinical Pharmacy, 2010. [Poster]
Zillich AJ, Jaynes HA, Schmelz AN, Gonzalvo JD, Doebbeling BN, Hudmon KS, Frankel RM. How physicians
and pharmacists communicate: Implications for patient safety. Presented at: American Colleges of Clinical Pharmacy, 2010. [Poster]
Warner M, Hudmon KS, Maio C. Barriers to physician assistant specialty change. Presented at:
Association of American Medical Colleges Workforce Meeting, 2010. [Poster]
KS Hudmon June 2017
Page 30
2011 Snyder ME, Pater KS, Lennox R, Hudmon KS, Doebbeling BN, Smith RB. A self‐administered questionnaire to identify patients at risk for medication‐related problems. Presented at ACRT/SCTS Annual Meeting, Washington, DC [poster] and at the Indiana CTSI Annual Meeting, Indianapolis, IN. [Poster]
2012 Hudmon KS, Corelli RL, Kroon LA. Rx for Change: Dissemination and implementation of a shared tobacco
cessation curriculum for pharmacy schools. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, FL, July 2012. [Poster]
Zillich AJ, Hudmon KS, Himstreet JE, Belperrio PS, Bolduc JA, Cyr M, Jorgensen R, Pruski DM, Cruz MP,
Cushnie S, Jaynes HA, Chen TC. Tobacco cessation training for Veterans Affairs pharmacists: A clinical pharmacy boot camp. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Kissimmee, FL, July 2012. [Poster]
Jin L, Barnoya J, Hudmon KS, Yun S, Schootman M. Geographic disparities in access to nonprescription nicotine replacement therapy in St. Louis pharmacies. Presented at: American Public Health Association Annual Meeting & Expo, San Francisco, CA, October 2012. [Poster]
2013 Corelli RL, Beechinor R, Creason M, Fong G, Cocohoba J, Vogt E, Tsourounis C, Hudmon KS. Evaluation of the multiple mini‐interview across stakeholders in a pharmacy school’s admission process. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Dallas, TX, July 2014. [Poster]
Chai T, Fairman M, Karic A, Baez K, Hudmon KS, Corelli RL. Tobacco and alcohol sales in community pharmacies: Policy statements from U.S. professional pharmacy associations. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Chicago, IL, July 2014. [Poster]
2014 Corelli RL, Kroon L, Vatanka P, Rodondi K, Hille B, Hudmon KS. Documentation of smoking status: Results
from a randomized trial to promote brief smoking cessation interventions in community pharmacies. Presented at: American Pharmacists Association (APhA) Annual Meeting & Exposition, Orlando, Florida, March 2014. [Poster]
Corelli RL, Beechinor R, Creason M, Fong G, Cocohoba J, Vogt E, Tsourounis C, Hudmon KS. Evaluation of
the multiple mini‐interview across stakeholders in a pharmacy school’s admission process. Presented at: American Association of Colleges of Pharmacy Annual Meeting, Dallas, TX, July 2014. [Poster]
Kernodle A, Kleyman S, Frail CK, Pater J, Hudmon KS, Doebbeling BN, Snyder ME. Use of a modified drug therapy concerns scale in community pharmacy practice: experience of patients and pharmacists. Presented at: American College of Clinical Pharmacy Annual Meeting, Austin, TX, October 2014. [Poster]
Gaur R, Kowalski RC, Montesa BM, Ziegler JR, Hudmon KS, Corelli RL. Post‐graduate residency application outcomes for University of California San Francisco Graduates, 2012‐2014. Presented at ASHP Midyear Meeting, December 2014. [Poster]
Muchnik M, Mehas N, Jaynes H, Hudmon KS, Klink S, Downey L, Zillich AJ. Baseline characteristics for patients enrolled in a randomized, controlled, medication adherence trial. Presented at ASHP Midyear Meeting, December 2014. [Poster]
KS Hudmon June 2017
Page 31
2015 Schwindt RG, McNelis AM, Hudmon KS, Lay K. Interprofessional collaboration to treat smokers with co‐occurring mental illness. Presented at: International Society of Psychiatric Nurses (ISPN). Seattle, WA, March 2015. [Poster]
Gaur R, Kowalski R, Montesa B, Ziegler J, Hudmon KS, Corelli RL. Post‐graduate residency application outcomes for University of California—San Francisco graduates 2012‐2014. Presented at 17th Annual Spring Seminar, University of California San Francisco, April 2015. [Poster] Hudmon KS, Kroon LA, Schwindt RG, Prokhorov AV, Corelli RL. Rx for Change: Development and dissemination of an inter‐professional, shared tobacco cessation curriculum. Presented at: Pharmacy Education Symposium, Prato, Italy, July 2015. [Poster] Corelli RL, Brock TP, Kusynova Z, Besancon L, Hudmon KS. Global sale of tobacco and electronic nicotine delivery systems in community pharmacies. Presented at: 75th FIP World Congress of Pharmacy and Pharmaceutical Sciences, Dusseldorf, Germany, October 2015. [Poster] Das S, Fromont S, Hudmon KS, Louie AK, Prochaska JJ. Dissemination of an evidence‐based tobacco treatment curriculum to psychiatry residency programs. Presented at: American Academy of Addiction Psychiatry, Huntington Beach, CA, December 2015. [Poster]
Yu J, Liu S, Corelli RL, Hudmon KS, Assemi MA. Educational attainment of deans and chairs at US schools of pharmacy in 2015. Presented at: ASHP Midyear Meeting, December 2014. [Poster]
2016 Corelli RL, Brock TP, Elkhadragy N, Kusynova Z, Besancon L, Hudmon KS. Global sale of tobacco and electronic nicotine delivery systems in community pharmacies. Presented at: UCSF 18th Annual Spring Research Seminar, San Francisco, CA, May 2016. [Poster; encore presentation]
Hudmon KS, Vitale F, Corelli RL, Elkhadragy N, Heeg M. Expanding the role of future respiratory
therapists in tobacco cessation. Presented at: Mayo Clinic Tobacco Dependence Treatment Summit, May 2016. [Poster]
Fu M, Mehas N, Jaynes H, Hudmon KS, Zillich AJ. Effect of drug class‐related symptoms on medication adherence in hypertensive patients. Presented at: International Society for Pharmacoeconomics and Outcomes Research, Washington DC, May 2016. [Poster] Schwindt R, Agley N, Hudmon KS, Lay K. An interprofessional team approach to treating tobacco dependence for persons with mental illness and co‐occurring disorders. Presented at: American Public Health Association Annual Meeting, Denver, CO, November 2016.
2017 Hudmon KS, de Moor C, Corelli RL, Zillich AJ, Prokhorov AV, Zbikowski SM. A randomized trial evaluating
two approaches for promoting pharmacy‐based referrals to the tobacco quitline. Presented at: Society for Research on Nicotine & Dependence, Florence, Italy, March 2017. [Poster]
Corelli RL, Schwindt RG, Krook LA, Prochaska J, Prokhorov AV, Hudmon KS. Development and
dissemination of a shared tobacco cessation curriculum for current and future healthcare professionals. Presented at: Society for Research on Nicotine & Dependence, Florence, Italy, March 2017. [Poster]
KS Hudmon June 2017
Page 32
Schwindt R, Hudmon KS, Lay K, Agley J, Corelli RL, McNelis RL, Bentley M. Training health professional students to treat tobacco dependence among persons with mental illness and co‐occurring disorders: A mixed‐methods study. Presented at: Society for Research on Nicotine & Dependence, Florence, Italy, March 2017. [Poster]
Research Awards, Fellowships, and Extramural Grants Current awards
Source: Indiana State Department of Health – Statewide Grant
Title: Reducing Tobacco Use Disparities among Patients with Mental Illness
Role: Principal Investigator
Personnel: D Hudson (co‐Investigator)
Time Period: 2017 – 2019
Amount: $250,000
Source: Pfizer, Inc.
Title: Expanding the Role of Future Respiratory Therapists in Tobacco Cessation
Role: Lead Scientific Investigator (primary author of grant but unpaid*)
Personnel: M Heeg, F Vitale
Time Period: 2015 – 2017
Amount: $146,161 * Dr. Hudmon’s participation in Pfizer‐sponsored projects is voluntary and unpaid, to avoid conflict of interest in her primary area of research and education.
Source: Purdue University College of Pharmacy Francke Award
Title: Impact of GoPro® Video Review on Student Self‐Assessment
Role: Co‐Principal Investigator
Personnel: A Isaacs (Co‐Principal Investigator); N Elkhadragy (co‐Investigator)
Time Period: 2015 – 2017
Amount: $2,500
Source: NIH/National Cancer Institute grant 1R25CA174665‐01A1
Title: Standardized Patients to Assess Competency in Tobacco Cessation Counseling
Role: Principal Investigator
Personnel: R Corelli (Co‐I), I Allard (co‐I), H Pohl (co‐I), G Vis (co‐I)
Time Period: 2014 – 2019
Amount: $1,624,203
KS Hudmon June 2017
Page 33
Past awards
Source: Indiana State Department of Health – Statewide Grant
Title: Bringing Indiana Along: Reducing Tobacco Use Disparities among Patients with Mental Illness
Role: Principal Investigator
Personnel: D Hudson (co‐Investigator)
Time Period: 2015 – 2017
Amount: $250,000
Source: Indiana University
Title: Tobacco Cessation Training for Health Professional Students Working with Seriously Mentally Ill Patients Who Smoke
Role: Co‐Investigator
Personnel: R Schwindt (PI), K Lay (co‐I)
Time Period: 2014 – 2016
Amount: $50,000
Source: NIH/National Cancer Institute grant R44‐SBIR Phase II
Title: The Effect of ScanCap Technology on Medication Adherence and Hypertension Outcomes (L Downey, Concordance, PI)
Role: Co‐Investigator
Personnel: A Zillich (PI of subcontract)
Time Period: 2012 – 2015
Amount: Total $351,428 subcontract; $1,027,421 total
Source: NIH/National Cancer Institute grant R01 CA 129312
Title: ASK, ADVISE, REFER: Promoting Pharmacy‐based Referrals to Tobacco Quit‐Lines
Role: Principal Investigator
Personnel: R Corelli (co‐I), A Prokhorov (co‐I), S Zbikowski (co‐I), A Zillich (co‐I)
Time Period: 2008 – 2013
Amount: $1,147,597
Source: University of California
Title: Dissemination of the Rx for Change in Psychiatry Curriculum
Role: Co‐Investigator
Personnel: J Prochaska (PI), S Fromont (co‐I), S Hall (co‐I)
Time Period: 2007 – 2010
Amount: $439,283
KS Hudmon June 2017
Page 34
Source: Pfizer, Inc.
Title: CS2day Gen II—Continuing Education Aimed at Smoking Cessation
Role: Principal Investigator (unpaid*)
Personnel: B Bennett
Time Period: 2010 – 2012
Amount: $306,121 * Dr. Hudmon’s participation in Pfizer‐sponsored projects is voluntary and unpaid, to avoid conflict of interest in her primary area of research and education.
Source: CME‐Enterprise
Title: Pharmacy‐based Tobacco Cessation Education
Role: Principal Investigator (unpaid; primary source of funding from Pfizer)
Personnel: B Bennett
Time Period: 2010 – 2012
Amount: $30,000
Source: Physicians Institute for Excellence in Medicine (PIEM)
Title: Motivational Interviewing for Tobacco Cessation
Role: Principal Investigator (unpaid; primary source of funding from Pfizer)
Personnel: B Bennett
Time Period: 2011 – 2012
Amount: $19,121
Source: IPMA
Title: The 5 A’s of Tobacco Cessation Counseling
Role: Principal Investigator (unpaid; primary source of funding from Pfizer)
Personnel: B Bennett
Time Period: 2011
Amount: $7,000
Source: Pfizer, Inc.
Title: CS2day Gen I—Continuing Education Aimed at Smoking Cessation
Role: Principal Investigator (unpaid; primary source of funding from Pfizer)
Personnel: B Bennett
Time Period: 2007 – 2010
Amount: $305,885
Source: Indiana Medicaid
Title: Effect of a Pharmacy Care Program (DailyMed) on Clinical and Economic Outcomes
Role: Co‐Investigator
Personnel: A Zillich (PI), I Kalsekar (co‐I), D French (co‐I), C deMoor (co‐I), Snyder M (co‐I)
Time Period: 2009 – 2010
Amount: $121,811
KS Hudmon June 2017
Page 35
Source: Veterans Affairs Health Services Research and Development
Title: STARS‐Stop Tobacco‐Attributable Risk After Stroke
Role: Co‐Investigator
Personnel: T. Damush (PI), A Zillich (Co‐I), L. Williams (Co‐I)
Time Period: 2008 – 2009
Amount: $74,912
Source: Eli Lilly Research Seed Grant
Title: Improving Patient Safety through Evidence‐based Prescribing
Role: Co‐Investigator
Personnel: A Zillich (PI), B Doebbeling (co‐I), R Frankel (co‐I)
Time Period: 2007 – 2009
Amount: $98,830
Source: Walther Cancer Center
Title: Enhancing Tobacco Cessation Counseling in Cancer Centers through Web‐based Learning
Role: Principal Investigator
Personnel: A Zillich (co‐I)
Time Period: 2007 – 2009
Amount: $29,423
Source: NIH/National Cancer Institute grant R25 CA90720
Title: Disseminating a Tobacco Curriculum for Pharmacy Students
Role: Principal Investigator
Personnel: R Corelli (co‐I), L Kroon (co‐I)
Time Period: 2002 – 2008
Amount: $784,279
Source: NIH/National Cancer Institute grant R01 CA93969
Title: Health‐Care Team Approach to Smoking Cessation
Role: Co‐Investigator (PI of subcontract)
Personnel: A Prokhorov (Principal Investigator), E Gritz (co‐I), D Wetter (co‐I), P Cinciripini (co‐I), S Cantor (co‐I)
Time Period: 2002 – 2008
Amount: $4,033,507
Source: NIH/National Institute of Dental and Craniofacial Research grant R01 DE015673
Title: Translating Dental Student Tobacco Education to Practice
Role: Co‐Investigator (PI of subcontract)
Personnel: K Rankin (Principal Investigator)
Time Period: 2003 – 2006
Amount: $1,094,865
KS Hudmon June 2017
Page 36
Source: Centers for Disease Control and Prevention
Title: Meeting Community Needs Across the Prevention Spectrum
Role: Co‐Investigator
Personnel: M Merson (Principal Investigator)
Time Period: 2004 – 2006 (participation ended upon relocation to Purdue)
Amount: $4,067,394
Source: Robert Wood Johnson Foundation/University of California
Title: Meeting Community Needs Across the Prevention Spectrum
Role: Subcontractor (Principal Investigator of subcontract)
Personnel: S Schroeder (Principal Investigator)
Time Period: 2003 – 2008 (subcontract to K Hudmon renewed annually)
Amount: $9,871,538
Source: University of California Tobacco‐Related Disease Research Program
Title: Transdermal Nicotine for Smokers with Schizophrenia
Role: Co‐Investigator (Principal Investigator of subcontract)
Personnel: M Smith (Principal Investigator)
Time Period: 2001 – 2006
Amount: $640,249
Source: University of California Tobacco‐Related Disease Research Program (program project grant)
Title: Project 1: Genetic & Environmental Influences on Tobacco Use
Role: Co‐Investigator (Project 1) and Scientific Liaison
Personnel: G Swan (Principal Investigator)
Time Period: 1999 – 2003
Amount: Program Project $3,447,746 Project 1 $865,519
Source: HRSA (Health Resources and Services Administration)
Title: California Poison Control System Evaluation of the California Poison Control System (Project 6)
Role: Principal Investigator of Project 6
Personnel: M Smith (Principal Investigator)
Time Period: 2002 – 2004
Amount: Project 6 $110,100
Source: University of California Tobacco‐Related Disease Research Program
Title: Prescription for Change
Role: Principal Investigator
Personnel: R Corelli (co‐I)
Time Period: 2001 – 2002
Amount: $11,257
KS Hudmon June 2017
Page 37
Source: Biogen, Inc.
Title: A Patient Persistency Program for Patients with Multiple Sclerosis
Role: Co‐Investigator
Personnel: B Berger (Principal Investigator)
Time Period: 2001 – 2003
Amount: $244,000
Source: University of California Tobacco‐Related Disease Research Program
Title: California Pharm‐Assists for Tobacco Cessation
Role: Co‐Principal Investigator
Personnel: M Shreve (co‐Principal Investigator), J Brigham (co‐Investigator)
Time Period: 1999 – 2001
Amount: $124,689
Source: NIH/National Cancer Institute R03 CA082058
Title: Characterizing Nicotine Replacement Therapy Users
Role: Principal Investigator
Personnel: None
Time Period: 1999 – 2001
Amount: $90,393
Source: University of California
Title: Prescription for Change: Finalization and Dissemination of a Tobacco Cessation Curriculum
Role: Co‐Investigator
Personnel: R Corelli (Principal Investigator)
Time Period: 2000 – 2001
Amount: $4,207
Source: University of California Tobacco‐Related Disease Research Program
Title: Nicotine Replacement Therapy: Pharmacists’ Counseling Role
Role: Principal Investigator
Personnel: None
Time Period: 1998 – 2000
Amount: $128,347
PUBLICATIONS Journal Articles ‐ Refereed (1) Allan EL, Hudmon KS, Berger BA, Eiland SA. Patient treatment adherence: Facility design and
counseling skills. Journal of Pharmacy Technology 1992;8(6):242‐251.
(2) Hudmon KS, Berger BA, Weaver JB. Psychometric development and evaluation of an instrument to
KS Hudmon June 2017
Page 38
measure acquisition of diabetes knowledge. American Journal of Pharmaceutical Education 1994;58(2):151‐156.
(3) Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. American Journal of Health‐System Pharmacy 1995;52(3):282‐287.
(4) Kinney AY, Hawkins R, Hudmon KS. Report of the Oncology Nursing Society's Oncology Nurse Practitioner Salary Survey. Oncology Nursing Forum 1996;23(10):1609‐1611.
(5) Hudmon KS, Stoltzfus C, Chamberlain RM, Lorimor RJ, Steinbach G, Winn RJ. Participants perceptions of a phase I colon cancer chemoprevention trial. Controlled Clinical Trials 1996;17:494‐508.
(6) Kinney AY, Hawkins R, Hudmon KS. A descriptive study of the role of the oncology nurse practitioner. Oncology Nursing Forum 1997;24(5):811‐820.
(7) Berger BA, Hudmon KS. Readiness for change: Implications for patient care. Journal of the American Pharmaceutical Association 1997;NS37:321‐329.
(8) Hudmon KS, Mullen PD, Nicol L, Hammond SK, Sockrider MM, Sajak T, Thompson J. The feasibility of telephone‐guided placement and removal of nicotine monitors for assessment of passive exposure to environmental tobacco smoke. Toxicology and Industrial Health 1997;13(1):73‐80.
(9) Hudmon KS, Honn SE, Jiang H, Chamberlain RM, Xiang W, Ferry G, Spitz MR. Identifying and recruiting healthy control subjects from a managed care organization: A methodology for molecular epidemiologic case‐control studies. Cancer Epidemiology Biomarkers & Prevention 1997;6:565‐571.
(10) Hudmon KS, Chamberlain RM, Frankowski RF. Outcomes of the placebo run‐in phase during the first two years of a head and neck cancer chemoprevention trial. Controlled Clinical Trials 1997;18:228‐240.
(11) Hudmon KS, Prokhorov AV, Koehly LM, DiClemente CC, Gritz ER. Psychometric properties of the Decisional Balance Scale and the Temptations to Try Smoking Inventory in adolescents. Journal of Child and Adolescent Substance Abuse 1997;6(3):1‐18.
(12) Prokhorov AV, Hudmon KS, Gritz ER. Promoting smoking cessation among cancer patients: A behavioral model. Oncology 1997;11(12):1807‐1813.
(13) Basen‐Engquist K, Hudmon KS, Tripp M, Chamberlain RM. Worksite health and safety climate: Scale development and effects of a health promotion intervention. Preventive Medicine 1998;27:111‐119.
(14) Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Wu, X. A case‐control study of the dopamine D2 receptor gene and smoking status in lung cancer. Journal of the National Cancer Institute 1998;90(5):358‐363.
(15) Gritz ER, Prokhorov AV, Hudmon KS, Chamberlain RM, Taylor WC, DiClemente CC, Johnston DA, Hu S, Jones LA, Jones MM, Rosenblum CK, Ayars CL, Amos CI. Cigarette smoking in a multi‐ethnic population of youth: Methods and baseline findings. Preventive Medicine 1998;27: 365‐384.
(16) Prokhorov AV, Koehly LM, Pallonen UE, Hudmon KS. Adolescent nicotine dependence measured by the Modified Fagerström Tolerance Questionnaire at two time points. Journal of Child and Adolescent Substance Abuse 1998;7(4):35‐47.
(17) Hudmon KS, Gritz ER, Clayton S, Nisenbaum R. Eating orientation as a predictor of weight gain following smoking cessation in a nonvolunteer population of female smokers. Health Psychology 1999;18:29‐36.
KS Hudmon June 2017
Page 39
(18) Hudmon KS, Love RR, Chamberlain RM. Perceived benefits and barriers of participation in a phaseI/II colon cancer chemoprevention trial. Journal of Cancer Education 1999;14(2):83‐87.
(19) Prokhorov AV, de Moor C, Pallonen UE, Hudmon KS, Koehly L, Hu S. Validation of the Modified Fagerström Tolerance Questionnaire with salivary cotinine among adolescents. Addictive Behaviors 2000;25(3):429‐433.
(20) Wu X, Hudmon KS, Detry MA, Chamberlain RM, Spitz MR. D2 dopamine receptor gene polymorphisms among African‐Americans and Mexican‐Americans: A lung cancer case‐control study. Cancer Epidemiology Biomarkers and Prevention 2000;9:1021‐1026.
(21) Prokhorov AV, Hudmon KS, de Moor CA, Kelder SH, Conroy JL, Ordway N. Nicotine dependence, withdrawal symptoms, and readiness to quit smoking among adolescents. Nicotine & Tobacco Research 2001;3(2):151‐155.
(22) Hudmon KS, Corelli RL, Kroon LA, Shreve MS, Prokhorov AV. Reducing pulmonary disease: The pharmacist’s role in smoking cessation. Journal of Pharmacy Practice 2001;XIV(2):143‐159.
(23) Corelli RL, Hudmon KS. Medications for smoking cessation. Western Journal of Medicine 2002;76:131‐35.
(24) Prokhorov AV, de Moor CA, Hudmon KS, Hu S, Kelder SH, Gritz ER. Predicting adolescent smoking initiation: Evidence for integrating the stages of change and susceptibility to smoking constructs. Addictive Behaviors 2002;27(5):697‐712.
(25) Mermelstein R, Colby SM, Patten C, Prokhorov A, Brown R, Myers M, Adelman W, Hudmon KS, McDonald P. Methodological issues in measuring treatment outcome in adolescent smoking cessation studies. Nicotine & Tobacco Research 2002;4(4): 395‐403.
(26) Prokhorov AV, Hudmon KS, Stancic N. Adolescent smoking: Epidemiology and approaches for achieving cessation. Pediatric Drugs 2003;5(1):1‐10.
(27) Hudmon KS, Corelli RL, Chung E, Gundersen B, Kroon LA, Sakamoto L, Hemberger KK, Fenlon C, Prokhorov AV. Development and statewide implementation of a tobacco cessation training program for California’s pharmacy schools. Journal of Cancer Education 2003;18:142‐149.
(28) Prokhorov AV, Warneke C, de Moor C, Emmons KM, Jones MM, Rosenblum C, Hudmon KS, Gritz ER. Self‐reported health status, health vulnerability, and smoking behavior in community college students: Implications for intervention. Nicotine & Tobacco Research 2003;5:545‐552.
(29) Gritz ER, Prokhorov AV, Hudmon KS, Jones MM, Rosenblum C, Chang CC, Chamberlain RM, Taylor WC, Johnston D, de Moor C. Predictors of susceptibility to smoking and ever smoking: A longitudinal study in a tri‐ethnic sample of adolescents. Nicotine & Tobacco Research 2003;5:492‐506.
(30) Hudmon KS, Marks JL, Pomerleau CS, Brigham J, Swan GE. A multidimensional model for characterizing tobacco dependence. Nicotine & Tobacco Research 2003;5:655‐664.
(31) Hudmon KS, Hemberger KK, Corelli RL, Kroon LA, Prokhorov AV. The role of the pharmacist in smoking cessation counseling: Perceptions of nonRx nicotine replacement therapy users. Journal of the American Pharmacists Association 2003;43:573‐82.
(32) Sockrider MM, Hudmon KS, Addy R, Mullen PD. Control of smoking in the home to reduce infant exposure to environmental tobacco smoke. Nicotine & Tobacco Research 2003;5:901‐10.
(33) Swan GE, Hudmon KS, Carmelli D, Hemberger KK, Khroyan T, Ring H, Cheng L, Hops H, Andrews J, Tildesley E, McBride D, Wilhelmsen K, Benowitz N, Koenig B, Iles J. Environmental and genetic
KS Hudmon June 2017
Page 40
determinants of adolescent tobacco use: a multidisciplinary, longitudinal family‐based design. Cancer Epidemiology Biomarkers & Prevention 2003;12:994‐1005.
(34) Hudmon KS, Kroon LA, Corelli RL, Saunders K, Bates T, Spitz MR, Liang D. Training future pharmacists at a minority educational institution: Evaluation of the Rx for Change tobacco cessation training program. Cancer Epidemiology Biomarkers & Prevention 2004;13(3):477‐81.
(35) Assemi M, Cullander C, Hudmon KS. Implementation and evaluation of a cultural competency training course for pharmacy students. Annals of Pharmacotherapy 2004;38(5):781‐786.
(36) Berger BA, Hudmon KS, Liang H. Predicting treatment discontinuation among patients with multiple sclerosis: An application of the Transtheoretical Model of Change. Journal of the American Pharmacists Association 2004; 44(4):445‐454.
(37) Eule B, Sullivan MK, Schroeder S, Hudmon KS. Merchandising cigarettes in San Francisco pharmacies: 27 years later. Tobacco Control 2004; 13(4):429‐432.
(38) Hudmon KS, Pomerleau C, Brigham J, Javitz H, Swan GE. Validity of retrospective assessments of tobacco dependence: a preliminary report. Addictive Behaviors 2005; 30(3):613‐7.
(39) Corelli RL, Kroon LA, Chung EP, Sakamoto LM, Gundersen B, Fenlon CM, Hudmon KS. Statewide evaluation of a tobacco cessation curriculum for pharmacy students. Preventive Medicine 2005; 40(6):888‐895.
(40) Hudmon KS, Bardel K, Kroon LA, Fenlon CM, Corelli RL. Tobacco education in U.S. schools of pharmacy. Nicotine & Tobacco Research 2005;7(2):225‐232.
(41) Berger BA, Liang D, Hudmon KS. Evaluation of a software‐based counseling intervention to enhance medication persistency among patients with multiple sclerosis. Journal of the American Pharmacists Association 2005; 45(4):466‐472.
(42) Prokhorov AV, Hudmon KS, Cinciripini P. “Withdrawal symptoms” in adolescents: a comparison of former smokers and never smokers. Nicotine & Tobacco Research 2005; 7(6):909‐13.
(43) Wilhelmsen KC, Swan GE, Cheng LS, Lessov CN, Amos C, Feiler HS, Hudmon KS, Ring HZ, Andrews JA, Tildesley E, Benowitz NL, Hops H. Support for previously identified alcoholism susceptibility loci in a cohort selected for smoking behavior. Alcoholism: Clinical and Experimental Research 2005;29(12):2108‐2115.
(44) Hudmon KS, Fenlon CM, Corelli RL, Prokhorov AV, Schroeder SA. Tobacco sales in pharmacies: Time to quit. Tobacco Control 2006; 15(1)35‐38.
(45) Hudmon KS, Prokhorov AV, Corelli RL. Tobacco cessation counseling: Pharmacists’ opinions and practices. Patient Education & Counseling 2006;61(1):152‐160.
(46) Hudmon KS, Kilfoy BA, Prokhorov AV. The epidemiology of tobacco use and dependence. Critical Care Nursing Clinics North America 2006;18(1):1‐11.
(47) Corelli RL, Hudmon KS. Pharmacological interventions for smoking cessation. Critical Care Nursing Clinics North America 2006;18(1):39‐51.
(48) Swan GE, Hops H, Wilhelmsen KC, Lessov‐Schlaggar CN, Cheng LS, Hudmon KS, Amos CI, Feiler HS, Ring HZ, Andrews JA, Tildesley E, Benowitz N. A genome‐wide screen for nicotine dependence susceptibility loci. American Journal of Medical Genetics B Neuropsychiatric Genetics. 2006;141(4):354‐60.
KS Hudmon June 2017
Page 41
(49) Hudmon KS, Hussar DA, Fenlon CM, Corelli RL. Pharmacy student perceptions of tobacco sales in pharmacies and suggested strategies for promoting tobacco‐free experiential sites. American Journal of Pharmaceutical Education 2006;70(4): article 75.
(50) Assemi M, Cullander C, Hudmon KS. Psychometric analysis of a scale assessing self‐efficacy for cultural competence in patient counseling. Annals of Pharmacotherapy 2006;40(12):2130‐2135.
(51) Kilfoy B, Prokhorov AV, Hudmon KS. Pharmacy placement of nonRx nicotine replacement therapy products and community pharmacists’ counseling for product use. Journal of the American Pharmacists Association 2006;46:723‐728.
(52) Sarino LV, Dang KH, Dianat N, Djihania H, Natanian, Hudmon KS, Ambrose P. Drug interactions between oral contraceptives and St. John’s Wort: Appropriateness of advice received from health food store clerks and community chain pharmacists. Journal of the American Pharmacists Association 2007;47(1):42‐47.
(53) Heath JE, Kelley FJ, Andrews J, Crowell N, Corelli RL, Hudmon KS. Evaluation of a tobacco cessation curricula intervention among acute care nurse practitioner faculty. American Journal of Critical Care Nursing 2007;16(3):284‐289.
(54) Prokhorov AV, Fouladi R, de Moor C, Warneke CL, Luca M, Mullin Jones M, Rosenblum C, Emmons KM, Hudmon KS, Gritz ER. Computer‐assisted, counselor‐delivered smoking cessation counseling for community college students: Intervention approach and sample characteristics. Journal of Child & Adolescent Substance Abuse 2007;16(3):35‐62.
(55) Kilfoy BA, Hudmon KS, Mande J. Tobacco control in state comprehensive cancer control plans: Opportunities for decreasing tobacco‐related disease. Preventing Chronic Disease 2007, 4(3):A61.
(56) Hudmon KS. The pharmacist’s role in tobacco cessation: Overview and introduction to the series. American Journal of Health System Pharmacists 2007;64(13):1434‐1436.
(57) Corelli RL, Fenlon CM, Kroon LA, Prokhorov AV, Hudmon KS. Evaluation of a train‐the‐trainer program for tobacco cessation. American Journal of Pharmaceutical Education 2007; 71(6): Article 109.
(58) Assemi M, Mutha S, Hudmon KS. Evaluation of a train‐the‐trainer program for cultural competence. American Journal of Pharmaceutical Education 2007; 71(6): Article 110.
(59) Lessov‐Schlaggar C, Hops H, Brigham J, Hudmon KS, Andrews JA, Tildesley E, McBride D, Jack LM, Javitz HS, Swan GE. Adolescent smoking trajectories and nicotine dependence. Nicotine & Tobacco Research 2008;10(2):341‐351.
(60) Prokhorov A, Yost T, Jones MM, de Moor C, Ford KH, Marani S, Kilfoy BA, Hein JP, Hudmon KS, Emmons KM. “Look at Your Health”: Outcomes associated with a computer‐assisted smoking cessation counseling intervention for community college students. Addictive Behaviors 2008;33(6)757‐771.
(61) Prokhorov AV, Kelder SH, Shegog R, Murray N, Peters R, Agurcia‐Parker C, Cinciripini PM, de Moor C, Conroy JL, Hudmon KS, Ford KH, Marani S. Impact of A Smoking Prevention Interactive Experience (ASPIRE), an interactive, multimedia smoking prevention and cessation curriculum for culturally diverse high school students, on smoking initiation at 18‐month follow‐up. Nicotine & Tobacco Research 2008;10(9):1477‐1485.
(62) Prochaska JJ, Fromont SC, Leek D, Hudmon KS, Louie AK, Jacobs MH, Hall SM. Evaluation of an evidence‐based tobacco treatment curriculum for psychiatry residency training programs. Academic Psychiatry 2008;32:484‐492.
KS Hudmon June 2017
Page 42
(63) Clague JN, Cinciripini P, Blalock J, Spitz MR, Wu X, Hudmon KS. The D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controls. Behavioral Genetics 2010;40(1):49‐58.
(64) Hudmon KS, Corelli RL. ASHP Therapeutic Position Statement on the Cessation of Tobacco Use. American Journal of Health‐Systems Pharmacy 2009;66:291‐307.
(65) Prochaska JJ, Fromont SC, Hudmon KS, Cataldo JK. Designing for dissemination: development of an evidence‐based tobacco treatment curriculum for psychiatry training programs. Journal of the American Psychiatric Nurses Association 2009;15(1):24‐31.
(66) Houston L, Warner M, Fenlon CM, Corelli RL, Hudmon KS. Tobacco education in U.S. physician assistant programs. Journal of Cancer Education 2009;14:107‐113.
(67) Nguyen JK, Hudmon KS, Lightwood J, Nicita K, Kotabe SE. Effect of dispensing supply on pravastatin refill adherence. American Journal of Pharmacy Benefits 2009;1(4):202‐208.
(68) Hudmon KS, Corelli RL, Prokhorov AV. Current approaches to pharmacotherapy for smoking cessation. Therapeutic Advances in Respiratory Disease 2010;40(1):49‐58.
(69) Bock BC, Hudmon KS, Christian JC, Graham AL, Bock FR. A tailored intervention to support pharmacy‐based counseling for smoking cessation. Nicotine & Tobacco Research 2010;12(3):217‐215.
(70) Schmelz AN, Nixon B, McDaniel A, Hudmon KS, Zillich AJ. Evaluation of an online tobacco cessation course for health‐professional students. American Journal of Pharmaceutical Education 2010; 74(2):Article 36.
(71) Prokhorov AV, Kelder SH, Shegog R, Conroy JL, Murray N, Peters R, Cinciripini PM, de Moor C, Hudmon KS, Ford KH. Project ASPIRE: An interactive, multimedia smoking prevention and cessation curriculum for culturally diverse high school students. Substance Use & Misuse 2010;45:938‐1006.
(72) Kim‐Katz SY, Anderson IB, Kearney TE, MacDougall C, Hudmon KS, Blanc PD. Topical antacid therapy for capsaicin‐induced dermal pain: A poison center telephone‐directed study. American Journal of Emergency Medicine 2010; 28(5): 596‐602.
(73) Zillich AJ, Hudmon KS, Damush T. Tobacco use and cessation among veterans recovering from stroke or TIA – A qualitative assessment and implications for rehabilitation. Topics in Stroke Rehabilitation 2010; 17(2): 140‐149.
(74) Prokhorov AV, Hudmon KS, Marani S, Foxhall L, Ford KH, Luca NS, Wetter DW, Cantor SB, Vitale F, Gritz ER. Engaging physicians and pharmacists in providing smoking cessation counseling. Archives of Internal Medicine 2010;170(18):1640‐1646.
(75) Lee KC, El‐Ibiary S, Hudmon KS. Evaluation of research training and productivity among junior pharmacy faculty in the U.S. Journal of Pharmacy Practice 2010;23(6):553‐559.
(76) Kao DJ, Hudmon KS, Corelli RL. Evaluation of a required senior research project in a Doctor of Pharmacy curriculum. American Journal of Pharmaceutical Education 2010;74(10): Article 190.
(77) Prochaska JJ, Benowitz, NL, Glanatz SA, Hudmon KS, Grossman W. Cardiology Rx for Change: Improving clinical attention to tobacco use and secondhand smoke exposure in cardiology. Clinical Cardiology 2011;34(12)738‐743.
(78) Hudmon KS, Addleton RL, Vitale FM, Christianson A, Mejicano GC. Advancing public health through continuing education of healthcare professionals. Journal of Continuing Education in the Health Professions 2011 Fall;31 (suppl 1:S60‐66).
KS Hudmon June 2017
Page 43
(79) Corelli RL, Kilfoy BA, Kim G, Ambrose PJ, Hudmon KS. Availability of tobacco and alcohol products in Los Angeles community pharmacies. Journal of Community Health 2012;37(1):113‐118.
(80) Hoch M, Hudmon KS, Lee L, Cupp R, Aragon L, Tyree RA, Corelli RL. Pharmacists’ perspectives of participation in a community pharmacy‐based nicotine replacement therapy distribution program. Journal of Community Health 2012;37(4):848‐854.
(81) Viteri E, Barnoya J, Hudmon KS, Solorzano PJ. Smoking cessation medications and cigarettes in Guatemala pharmacies. Tobacco Control 2012;21(5):477‐481.
(82) Gonzalvo J, Schmelz A, Hudmon KS. Community pharmacists’ and technicians’ communication with Spanish‐speaking patients: A needs assessment. Journal of the American Pharmacists Association 2012;52(3):363‐366.
(83) Zillich AJ, Jaynes H, Snyder ME, Harrison J, Hudmon KS, de Moor C, French DD. Evaluation of medication therapy management combined with medication compliance packaging: Adherence, outcomes, and costs among Medicaid patients. Medical Care 2012;50(6):485–493.
(84) Lee KC, Ma JD, Hudmon KS, Kuo GM. A train‐the‐trainer approach to a shared pharmacogenomics curriculum for US colleges and schools of pharmacy. American Journal of Pharmaceutical Education 2012;76(10):193.
(85) Prokhorov AV, Hudmon KS, Marani SK, Bondy ML, Gatus LA, Spitz MR, Wilkinson AV, Hammond SK, Koehly LM. Eliminating second‐hand smoke from Mexican‐American households: Outcomes from Project Clean Air – Safe Air (CASA). Addictive Behaviors 2012;38(1):1485‐1492.
(86) Zillich AJ, Corelli RL, Zbikowski S, Magnusson BL, Fenlon CF, Prokhorov AV, de Moor C, Hudmon KS. A randomized trial evaluating 2 intervention approaches for promoting pharmacy‐based referrals to the tobacco quitline: Methods and baseline findings. Research in Social and Administrative Pharmacy 2013; 9(1):27‐36.
(87) Hoch MA, Ott CA, Hudmon KS, Plake KS. Attitudes of individuals with schizophrenia toward pharmacists. Journal of the American Pharmacists Association 2012;52(6):783‐786.
(88) Warner ML, Maio C, Hudmon KS. Career patterns of physician assistants: A retrospective longitudinal study. JAAPA 2013;26(6):44‐8.
(89) McBane SE, Corelli RL, Albano CB, Conry JM, Della Paolera MA, Kennedy AK, Jenkins AT, Hudmon KS. The role of academic pharmacy in tobacco cessation and control. American Journal of Pharmaceutical Education 2013;77(5):93.
(90) Corelli RL, de Moor C, Zillich AJ, Fenlon CF, Zbikowski S, Prokhorov AV, Hudmon KS. Recruitment of community pharmacies in a randomized trial to generate patient referrals to the tobacco quitline. Research in Social and Administrative Pharmacy 2013;9(4):396‐404.
(91) Kroon LA, Corelli RL, Roth AP, Hudmon KS. Public perceptions of the ban on tobacco sales in San Francisco pharmacies. Tobacco Control 2013;22(6):369‐371.
(92) Wahl KR, Woolf BL, Hoch MA, Zillich AJ, Hudmon KS. Promoting pharmacy‐based referrals to the tobacco quitline: A pilot study of academic detailing administered by pharmacy students. Journal of Pharmacy Practice 2015;29(2):162‐165.
(93) Corelli RL, Chai T, Karic A, Fairman M, Baez K, Hudmon KS. Tobacco and alcohol sales in community pharmacies: Policy statements from U.S. professional associations. Journal of the American Pharmacists Association 2014;54(3):285‐288.
KS Hudmon June 2017
Page 44
(94) Polansky M, Ross AC, Coniglio D, Garino A, Hudmon KS. Cancer education in physician assistant programs. J Physician Assist Educ 2014;25(1):4‐11.
(95) Hudmon KS, Hoch MA, Vitale FM, Wahl KR, Corelli RL, de Moor C. Tobacco cessation education for community pharmacists: Face‐to‐face presentations versus live webinars. Journal of the American Pharmacists Association 2014;54:42‐4.
(96) Hudmon KS, Livin AL, Corelli RL, Fenlon CM, Schroeder SA. Tobacco education in U.S. respiratory care programs. Nicotine & Tobacco Research 2014;16(10:1394‐1398.
(97) Snyder ME, Pater KS, Frail CK, Hudmon KS, Doebbeling BN, Smith RB. Utility of a brief screening tool for medication‐related problems. Research in Social and Administrative Pharmacy 2015;11(2):253‐264.
(98) Chen T, Hamlett‐Berry KW, Watanabe JH, Bounthavong M, Zillich AJ, Christofferson DE, Myers MG, Himstreet JE, Belperio PS, Hudmon KS. Evaluation of a multidisciplinary tobacco cessation training program in a large health care system. American Journal of Health Education 2015;46(3);165‐173.
(99) Brock TP, Assemi M, Corelli RL, El‐Ibiary SY, Kavookjian J, Martin BA, Hudmon KS. A nontraditional faculty development initiative using a social media platform. American Journal of Pharmaceutical Education 2014;78(5):105.
(100) Lee KC, Hudmon KS, Ma JD, Kuo GM. Evaluation of a shared pharmacogenomics curriculum for pharmacy students. Pharmacogenomics 2015;16(4):315‐322.
(101) Barnoya J, Jin L, Hudmon KS, Schootman M. Disparities in pricing and access to nicotine replacement therapy, tobacco products, and electronic cigarettes in pharmacies in St. Louis, Missouri. Journal of the American Pharmacists Association 2015;55(4):405‐412.
(102) Schwindt RL, Hudmon KS. Working together to combat tobacco use. Archives of Psychiatric Nursing 2015;29(6):474.
(103) Corelli RL, Muchnik MA, Beechinor R, Fong G, Vogt EM, Cocohoba JM, Tsourounis C, Hudmon KS. Perceptions and Cost‐Analysis of a multiple mini‐interview in a pharmacy school admissions process. American Journal of Pharmaceutical Education 2015;79(9):Article 135.
(104) Bergman AA, Zillich AJ, Jaynes HA, Kobylinski AL, Gonzalvo J, Hudmon KS, Frankel RM. Pharmaceutical role expansion and developments in pharmacist‐physician communication. Health Communication 2016;31(2):161‐170.
(105) Rider K, Kaya H, Jha V, Hudmon KS. Attitudes of directors of experiential education regarding tobacco sales in pharmacies in the USA. International Journal of Pharmacy Practice 2016;24(2):134‐138.
(106) Assemi M, Hudmon KS, Sowinski KM, Corelli RL. Educational background and academic rank within US schools of pharmacy. American Journal of Pharmaceutical Education 2016;80(4):Article 61.
(107) Barboza JL, Patel R, Patel P, Hudmon KS. An update on the pharmacotherapeutic interventions for smoking cessation. Expert Opinion on Pharmacotherapy 2016;20:1‐14.
(108) Assemi M, Yu J, Liu S, Corelli RL, Hudmon KS. Educational attainment and academic profiles of Deans and Chairs at US schools of pharmacy. American Journal of Pharmaceutical Education, in press.
(109) Hudmon KS, Elkhadragy N, Kusynová Z, Besançon L, Brock TP, Corelli RL. Global sale of tobacco products and electronic nicotine delivery systems in community pharmacies. Tobacco Control, in press.
KS Hudmon June 2017
Page 45
Submitted manuscripts
(1) Schwindt R, Agley J, McNelis A, Hudmon KS, Lay K, Bentley M. Validation of the Interprofessional Collaborative Competency Attainment Survey (ICCAS) to assess interprofessional education and collaboration among graduate health professions students in the United States.
(2) Corelli RL, Mehas NA, Cheung K, Ankrah DO, Blatt MW, Hudmon KS. Experience with a shared tobacco cessation curriculum in California schools of pharmacy (2000‐2013).
(3) Lee KC, Ma JD, Hudmon KS, Kuo GM. Implementation of a shared pharmacogenomics curriculum in pharmacy schools.
Invited Book Chapters
(1) Swan GE, Hudmon KS, Khroyan TV. Tobacco Dependence. In Nezu AM, Nezu C M, Geller PA, eds. Health Psychology, Volume 9 of the Handbook of Psychology, Editor‐in‐chief, Weiner IB. New York: Wiley, 2003.
(2) Corelli RL, Hudmon KS, Kroon LA. Tobacco Dependence. In Handbook of NonRx Drugs: An Interactive Approach to Self‐Care, 14th Ddition. Berardi RR, McDermott JH, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, eds. American Pharmaceutical Association: Washington, DC, 2004.
(3) Corelli RL, Hudmon KS. Tobacco Use and Dependence. In Applied Therapeutics: The Clinical Use of Drugs, 8th Edition. Koda‐Kimble MA, Young LY, eds. Lippincott, Williams & Wilkins: Baltimore, MD, 2004.
(4) Hudmon KS, Kroon LA, Corelli RL. Smoking Cessation. In Handbook of Nonprescription Drugs: An Interactive Approach to Self‐Care, 15th Edition. Berardi RR, Kroon LA, McDermott JH, Newton GD, Oszko MA, Popovich NG, Remington TL, Rollins CJ, Shimp LA, Tietze KJ, eds. American Pharmacists Association: Washington, DC, 2006.
(5) Corelli RL, Hudmon KS. Tobacco Use and Dependence. In Applied Therapeutic, 9th Edition. Koda‐Kimble MA, Young LY, Kradjan W, Guglielmo J, Alldredge B, Corelli RL, eds. Lippincott, Williams & Wilkins: Baltimore, MD, 2008.
(6) Prokhorov AV, Ford KH, Hudmon KS. Smoking Cessation. In Lung Cancer, 3rd Edition. Roth J, Hong WK, Cox J, eds. Blackwell Publishing, United Kingdom, 2008.
(7) Corelli RL, Hudmon KS. Tobacco Use and Dependence. In The Handbook of Applied Therapeutics, 9th Edition. Koda‐Kimble MA, Young LY, Kradjan W, Guglielmo J, Alldredge B, Corelli RL, Williams BR, eds. Lippincott, Williams & Wilkins: Baltimore, MD, 2008.
(8) Zillich AJ, Vitale F, Hudmon KS. Strategies to Enhance Tobacco Cessation Education in Your Hospital. In: McNeil MJ, ed. ASHP’s Safety and Quality Pearls. American Society of Health‐System Pharmacists: Washington DC, 2008.
(9) Hudmon KS. Health Promotion and Evaluation. In Social and Behavioral Aspects of Pharmaceutical Care, 2nd Edition. Rickels N, Wertheimer AI, Smith MC, eds. Jones and Bartlett: Boston, MA, 2009.
(10) Kroon LA, Corelli RL, Hudmon KS. Smoking Cessation. In Handbook of Nonprescription Drugs: An Interactive Approach to Self‐Care, 16th Edition. Berardi RR, McDermott JH, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, eds. American Pharmaceutical Association: Washington, DC, 2009.
KS Hudmon June 2017
Page 46
(11) Corelli RL, Hudmon KS. Tobacco Use and Dependence. In The Handbook of Applied Therapeutic, 8th Edition. Lippincott, Williams & Wilkins: Baltimore, MD, 2006.
(12) Hudmon KS, Kroon LA, Corelli RL. Smoking Cessation. In Handbook of Nonprescription Drugs: An Interactive Approach to Self‐Care, 17th Edition. Berardi RR, McDermott JH, Newton GD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, eds. American Pharmaceutical Association: Washington, DC, 2012.
(13) Hudmon KS, Corelli RL, Prokhorov AV. Smoking Cessation Therapies and Programs. In Encyclopedia of Lifestyle Medicine and Health. Rippe JM, ed. Sage Publications, 2012.
(14) Corelli RL, Hudmon KS. Tobacco Use and Dependence. In The Handbook of Applied Therapeutics, 10th Edition. Alldredge B, Corelli RL, Ernst ME, Guglielmo J, Jacobson PA, Kradjan W, Williams BR, eds. Lippincott, Williams & Wilkins: Baltimore, MD, 2012.
(15) Prokhorov AV, Hudmon KS. Smoking Cessation. In Lung Cancer, 4rd Edition. Roth J, Hong WK, Cox J, eds. Blackwell Publishing, United Kingdom, 2014.
Masters Thesis and Doctoral Dissertation
Suchanek KL. The construction of a test instrument for measuring the acquisition of information provided by USP DI Visualized “About Your Diabetes.” School of Pharmacy, Auburn University, 1991.
Hudmon KS. Behavioral facets of cancer chemoprevention trials. School of Public Health, The University of Texas, 1995.
Abstracts, Reports, Continuing Education Monographs and Programs, Letters, Editorials, Invited Blogs, Non‐refereed Articles (1) Hudmon KS, Kinney AY. Issues of enrollment bias in cancer chemoprevention trials. Cancer Bulletin
1995, 47:339‐342. (2) Hudmon KS, Swan GE. Genetics and nicotine dependence: An update and call for integration. Society
for Research on Nicotine and Tobacco Newsletter 1998; 4(3):10‐11 [newsletter contribution].
(3) Corelli RL, Hudmon KS. Promoting treatment adherence in diabetes: A practical strategy for pharmacists. California Journal of Health‐System Pharmacy 1999, September/October; 11(5): 12‐16.
(4) Prokhorov AV, Hudmon KS. Cessation? Treatment? Readers weigh options. Society for Research on Nicotine and Tobacco Newsletter 2000; 5(4):13 [letter to the editor].
(5) Hudmon KS, Corelli RL. California pharmacy schools adopt tobacco curriculum. Society for Research on Nicotine and Tobacco Newsletter 2000; April:13‐14 [newsletter contribution].
(6) Hudmon KS, Shreve MS. No ifs, ands, or butts…Your pharmacist can help you quit smoking. California Health, California State Board of Pharmacy [column], Fall 2000.
(7) Hudmon KS, Corelli RL, Berger BA. Treating tobacco use and dependence. Rx Consultant 2001:10(9):1‐7. [1.5 hours of ACPE‐approved continuing pharmaceutical education].
(8) Berger BA, Lloyd KB, Hudmon KS. The pharmacists’ role in smoking cessation: Part 1, getting started. U.S. Pharmacist 2001; 26(5):57‐64.
KS Hudmon June 2017
Page 47
(9) Berger BA, Lloyd KB, Hudmon KS. The pharmacist’s role in smoking cessation: Part 2. U.S. Pharmacist 2001; 26(7):56‐62.
(10) Berger BA, Hudmon KS, Lloyd KB. The pharmacist’s role in smoking cessation: Part 3. U.S. Pharmacist 2001; 26(9):47‐54.
(11) Berger BA, Hudmon KS, Lloyd KB. The pharmacist’s role in smoking cessation: Part 4. U.S. Pharmacist, 2001, 26(11): 56‐62.
(12) Lloyd KB, Hudmon KS, Berger BA. The pharmacist’s role in smoking cessation: Part 5. U.S. Pharmacist 2002, 27(1):41‐46.
(13) Berger BA, Hudmon KS, Corelli RL, Lloyd KB. The pharmacist’s role in smoking cessation: Part 6. U.S. Pharmacist, 2002, 27(2): 32‐38.
(14) Corelli RL, Hudmon KS, Berger BA. Smoking cessation. The Rx Consultant, 2004. [1.5 hours of ACPE‐approved continuing pharmaceutical education].
(15) Hudmon KS. Guest editorial on the pharmacists’ role in tobacco cessation. Canadian Pharmaceutical Journal, April 2005.
(16) Hudmon KS, LaCivita C. Creating a road map for pharmacy’s role in the cessation of tobacco use. Am J Health‐Syst Pharm 2006;63:564‐566.
(17) Zillich AJ, Corelli RL, Hudmon KS. Smoking cessation for the Busy Clinician. The Rx Consultant, 2008. [1.5 hours of ACPE‐approved continuing pharmaceutical education].
(18) Corelli RL, Kroon LA, Hudmon KS. Smoking Cessation for the Busy Clinician. The Rx Consultant, 2014. [2.0 hours of ACPE‐approved continuing pharmaceutical education].
(19) Martin B, Hudmon KS, Corelli RL. Tobacco Cessation: Pocketbook Toolkit. Pharmacy Society of Wisconsin – Pharmacy Quality Collaborative, 2014.
(20) Integrating Medications into Smoking Cessation Treatment: The Basics. Co‐presented with Dr. Robin Corelli, webinar hosted by the UCSF Smoking Cessation Leadership Center, September 2015. [3.0 hours of continuing education].
(21) Beyond the Basics: Pharmacotherapy for Smoking Cessation. Co‐presented with Dr. Robin Corelli, webinar hosted by the UCSF Smoking Cessation Leadership Center, March 2016. [2.0 hours of continuing education].
(22) Kroon LA, Corelli RL, Hudmon KS. Furnishing Nicotine Replacement Therapy: Smoking Cessation Training Program for Pharmacists. Created for the California Pharmacists Association in preparation for the launch of Senate Bill 493 to expand role of pharmacists in tobacco cessation, 2016. [2.0 hours of ACPE‐approved continuing pharmaceutical education].
(23) Hudmon KS. Tobacco Free for Recovery: Assisting Tobacco‐Addicted Individuals with Tobacco Recovery. Accredited continuing education program for peer counselors, created for and hosted by Affiliated Service Providers of Indiana (ASPIN), September 2016. [1.5 hours]
(24) Elkhadragy N, Hudmon KS. Quitting Smoking for Good. Home Health Quality Improvement (invited blog story), November 2016.
(25) Schwindt R, Elkhadragy N, Hudmon KS. Helping your Clients Quit Smoking (Part 2). International Society of Psychiatric‐Mental Health Nurses newsletter, November 2016.
Published Expert Comment and Research‐Related Lay Press (selected)
KS Hudmon June 2017
Page 48
O, The Oprah Magazine. O’s Smoking Challenge. January 2007. (interviewed and quoted) Pharmacy Practice News. Helping Cancer Patients Quit Smoking Pays Off. May 2011. (interviewed and quoted) Associated Press. Purdue gets $1.6M to Create Virtual Patients. December 2014. Purdue Profiles: Spotlight on Karen Hudmon. February 2016. http://www.purdue.edu/newsroom/purduetoday/purdueprofiles/2016/Q1/purdue‐profiles‐karen‐hudmon.html Drug Topics. How Pharmacists are Helping Patients Kick the Habit. Pharmacist‐led smoking‐cessation programs work. June 2016. (interviewed and quoted) Pharmacy Today. E‐cigarettes: Evolving Research, Regulations Keep Pharmacists on their Toes. July 2016. (interviewed and quoted) Purdue University News Release. Tobacco Cessation Summit set in Indianapolis. August 2016. (quoted) Purdue University Alumni. Big Idea: Faculty share transformative visions for our future. Make a tobacco‐free lifestyle a basic human right. September, 2016.
KS Hudmon June 2017
Page 49
Televised Interviews and News Stories 1999 Interviewed by ABC News, for ABC World News Tonight, on the genetics of tobacco dependence.
Aired nationally on Sunday, January 24, 1999. 2003 Interviewed by KRON‐TV, for Good Morning Sacramento, on the topic of methods for treating
tobacco use and dependence. Aired locally on Friday, April 18, 2003. 2016 Big 10 Network news story (aired on national television), on the topic of Rx for Change, November
2016. Available at: https://www.youtube.com/watch?v=diGxmA_woWI. Contact Information Karen S. Hudmon, DrPH, MS, BSPharm Professor of Pharmacy Practice Department of Pharmacy Practice Purdue University College of Pharmacy 640 Eskenazi Avenue, 3rd Floor Indianapolis, IN 46202 Office: 317 880 5427; Mobile: 317 937 1991 e‐mail: [email protected]